CA3033788A1 - Nucleic acid products and methods of administration thereof - Google Patents

Info

Publication number

CA3033788A1

CA3033788A1 CA3033788A CA3033788A CA3033788A1 CA 3033788 A1 CA3033788 A1 CA 3033788A1 CA 3033788 A CA3033788 A CA 3033788A CA 3033788 A CA3033788 A CA 3033788A CA 3033788 A1 CA3033788 A1 CA 3033788A1

Authority

CA

Canada

Prior art keywords

disease

optionally

defective gene

gene

synthetic rna

Prior art date

2016-08-17

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 238000000034 method Methods 0.000 title claims abstract description 281
• 102000039446 nucleic acids Human genes 0.000 title abstract description 128
• 108020004707 nucleic acids Proteins 0.000 title abstract description 128
• 150000007523 nucleic acids Chemical class 0.000 title abstract description 128
• 108090000623 proteins and genes Proteins 0.000 claims abstract description 447
• 102000004169 proteins and genes Human genes 0.000 claims abstract description 168
• 238000010362 genome editing Methods 0.000 claims abstract description 102
• 239000003814 drug Substances 0.000 claims abstract description 80
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 326
• 201000010099 disease Diseases 0.000 claims description 292
• 230000002950 deficient Effects 0.000 claims description 276
• 125000002680 canonical nucleotide group Chemical group 0.000 claims description 157
• 235000018102 proteins Nutrition 0.000 claims description 154
• 210000004027 cell Anatomy 0.000 claims description 140
• 238000002347 injection Methods 0.000 claims description 105
• 239000007924 injection Substances 0.000 claims description 105
• 239000000203 mixture Substances 0.000 claims description 94
• 125000003729 nucleotide group Chemical group 0.000 claims description 85
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 80
• 239000002773 nucleotide Substances 0.000 claims description 79
• 101710163270 Nuclease Proteins 0.000 claims description 68
• 238000011282 treatment Methods 0.000 claims description 64
• 241000282414 Homo sapiens Species 0.000 claims description 54
• ZAYHVCMSTBRABG-JXOAFFINSA-N 5-methylcytidine Chemical compound O=C1N=C(N)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 ZAYHVCMSTBRABG-JXOAFFINSA-N 0.000 claims description 52
• QXDXBKZJFLRLCM-UAKXSSHOSA-N 5-hydroxyuridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(O)=C1 QXDXBKZJFLRLCM-UAKXSSHOSA-N 0.000 claims description 45
• 230000007541 cellular toxicity Effects 0.000 claims description 45
• JRYMOPZHXMVHTA-DAGMQNCNSA-N 2-amino-7-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-pyrrolo[2,3-d]pyrimidin-4-one Chemical compound C1=CC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O JRYMOPZHXMVHTA-DAGMQNCNSA-N 0.000 claims description 40
• ZAYHVCMSTBRABG-UHFFFAOYSA-N 5-Methylcytidine Natural products O=C1N=C(N)C(C)=CN1C1C(O)C(O)C(CO)O1 ZAYHVCMSTBRABG-UHFFFAOYSA-N 0.000 claims description 40
• 229910052757 nitrogen Inorganic materials 0.000 claims description 40
• DWRXFEITVBNRMK-JXOAFFINSA-N ribothymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 DWRXFEITVBNRMK-JXOAFFINSA-N 0.000 claims description 39
• 208000035475 disorder Diseases 0.000 claims description 32
• DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 claims description 30
• PTJWIQPHWPFNBW-GBNDHIKLSA-N pseudouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-GBNDHIKLSA-N 0.000 claims description 30
• NFEXJLMYXXIWPI-JXOAFFINSA-N 5-Hydroxymethylcytidine Chemical compound C1=C(CO)C(N)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NFEXJLMYXXIWPI-JXOAFFINSA-N 0.000 claims description 29
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 claims description 29
• 108091081062 Repeated sequence (DNA) Proteins 0.000 claims description 29
• 108010050122 alpha 1-Antitrypsin Proteins 0.000 claims description 29
• 238000009472 formulation Methods 0.000 claims description 29
• 101000899361 Homo sapiens Bone morphogenetic protein 7 Proteins 0.000 claims description 27
• 229930185560 Pseudouridine Natural products 0.000 claims description 27
• PTJWIQPHWPFNBW-UHFFFAOYSA-N Pseudouridine C Natural products OC1C(O)C(CO)OC1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-UHFFFAOYSA-N 0.000 claims description 27
• 150000001413 amino acids Chemical group 0.000 claims description 27
• WGDUUQDYDIIBKT-UHFFFAOYSA-N beta-Pseudouridine Natural products OC1OC(CN2C=CC(=O)NC2=O)C(O)C1O WGDUUQDYDIIBKT-UHFFFAOYSA-N 0.000 claims description 27
• 230000005782 double-strand break Effects 0.000 claims description 27
• 102100022712 Alpha-1-antitrypsin Human genes 0.000 claims description 26
• 208000030159 metabolic disease Diseases 0.000 claims description 26
• 102100022544 Bone morphogenetic protein 7 Human genes 0.000 claims description 25
• 238000010459 TALEN Methods 0.000 claims description 25
• 229940024142 alpha 1-antitrypsin Drugs 0.000 claims description 25
• 229910052717 sulfur Inorganic materials 0.000 claims description 25
• HITGTSFRKOQULY-DKZDHXMOSA-N 5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound CC1([C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)C=NC(=O)NC1=O HITGTSFRKOQULY-DKZDHXMOSA-N 0.000 claims description 24
• 230000004568 DNA-binding Effects 0.000 claims description 24
• 230000003197 catalytic effect Effects 0.000 claims description 24
• 230000007423 decrease Effects 0.000 claims description 24
• 229910052739 hydrogen Inorganic materials 0.000 claims description 24
• UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical group O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 claims description 23
• 150000002632 lipids Chemical class 0.000 claims description 23
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims description 22
• 238000001727 in vivo Methods 0.000 claims description 21
• ZXIATBNUWJBBGT-JXOAFFINSA-N 5-methoxyuridine Chemical compound O=C1NC(=O)C(OC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 ZXIATBNUWJBBGT-JXOAFFINSA-N 0.000 claims description 19
• 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 19
• 108091033409 CRISPR Proteins 0.000 claims description 18
• 108010041834 Growth Differentiation Factor 15 Proteins 0.000 claims description 18
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical group C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 claims description 18
• -1 ICOS Proteins 0.000 claims description 18
• SKRPUDFNLCXIOY-ZEQWWUPGSA-N 5-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxypyrimidine-2,4-dione Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1(O)C(=O)NC(=O)N=C1 SKRPUDFNLCXIOY-ZEQWWUPGSA-N 0.000 claims description 17
• 102100021860 Endothelial cell-specific molecule 1 Human genes 0.000 claims description 17
• 101710153170 Endothelial cell-specific molecule 1 Proteins 0.000 claims description 17
• MPPUDRFYDKDPBN-UAKXSSHOSA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxypyrimidin-2-one Chemical compound C1=C(O)C(N)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 MPPUDRFYDKDPBN-UAKXSSHOSA-N 0.000 claims description 16
• 230000007812 deficiency Effects 0.000 claims description 16
• SVRWPYGLQBPNNJ-UAKXSSHOSA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidine-5-carboxylic acid Chemical compound C1=C(C(O)=O)C(N)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 SVRWPYGLQBPNNJ-UAKXSSHOSA-N 0.000 claims description 15
• 229940024606 amino acid Drugs 0.000 claims description 15
• 235000001014 amino acid Nutrition 0.000 claims description 15
• 239000002502 liposome Substances 0.000 claims description 15
• 210000002966 serum Anatomy 0.000 claims description 15
• OCMSXKMNYAHJMU-JXOAFFINSA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidine-5-carbaldehyde Chemical compound C1=C(C=O)C(N)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 OCMSXKMNYAHJMU-JXOAFFINSA-N 0.000 claims description 14
• IZFJAICCKKWWNM-JXOAFFINSA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methoxypyrimidin-2-one Chemical compound O=C1N=C(N)C(OC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IZFJAICCKKWWNM-JXOAFFINSA-N 0.000 claims description 14
• 108091008036 Immune checkpoint proteins Proteins 0.000 claims description 14
• 206010028980 Neoplasm Diseases 0.000 claims description 14
• 230000001965 increasing effect Effects 0.000 claims description 14
• 238000006467 substitution reaction Methods 0.000 claims description 14
• AAAANSSZMCYGTA-UAKXSSHOSA-N 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidine-5-carboxylic acid Chemical compound OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cc(C(O)=O)c(=O)[nH]c1=O AAAANSSZMCYGTA-UAKXSSHOSA-N 0.000 claims description 13
• MZBPLEJIMYNQQI-JXOAFFINSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidine-5-carbaldehyde Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(C=O)=C1 MZBPLEJIMYNQQI-JXOAFFINSA-N 0.000 claims description 13
• VQAJJNQKTRZJIQ-JXOAFFINSA-N 5-Hydroxymethyluridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(CO)=C1 VQAJJNQKTRZJIQ-JXOAFFINSA-N 0.000 claims description 13
• JYKAFZZHVAAKHC-DKZDHXMOSA-N 5-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methoxypyrimidine-2,4-dione Chemical compound COC1([C@H]2[C@H](O)[C@H](O)[C@@H](CO)O2)C=NC(=O)NC1=O JYKAFZZHVAAKHC-DKZDHXMOSA-N 0.000 claims description 13
• ODQXKFNNFMNBBQ-DKZDHXMOSA-N 5-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,6-dioxopyrimidine-5-carbaldehyde Chemical compound C(=O)C1([C@H]2[C@H](O)[C@H](O)[C@@H](CO)O2)C=NC(=O)NC1=O ODQXKFNNFMNBBQ-DKZDHXMOSA-N 0.000 claims description 13
• XPCZYMYCOPFRNX-IIBRLFBTSA-N 5-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,6-dioxopyrimidine-5-carboxylic acid Chemical compound C(=O)(O)C1([C@H]2[C@H](O)[C@H](O)[C@@H](CO)O2)C=NC(=O)NC1=O XPCZYMYCOPFRNX-IIBRLFBTSA-N 0.000 claims description 13
• SMVXVEMFZNGPOA-DKZDHXMOSA-N 5-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(hydroxymethyl)pyrimidine-2,4-dione Chemical compound OCC1([C@H]2[C@H](O)[C@H](O)[C@@H](CO)O2)C=NC(=O)NC1=O SMVXVEMFZNGPOA-DKZDHXMOSA-N 0.000 claims description 13
• 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 claims description 13
• 230000000694 effects Effects 0.000 claims description 13
• 230000028993 immune response Effects 0.000 claims description 13
• 230000004054 inflammatory process Effects 0.000 claims description 13
• 238000001990 intravenous administration Methods 0.000 claims description 13
• 229910052700 potassium Inorganic materials 0.000 claims description 13
• 238000013518 transcription Methods 0.000 claims description 13
• 102100036475 Alanine aminotransferase 1 Human genes 0.000 claims description 12
• 108010082126 Alanine transaminase Proteins 0.000 claims description 12
• 108010003415 Aspartate Aminotransferases Proteins 0.000 claims description 12
• 102000004625 Aspartate Aminotransferases Human genes 0.000 claims description 12
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 12
• 108010017070 Zinc Finger Nucleases Proteins 0.000 claims description 12
• 239000000539 dimer Substances 0.000 claims description 12
• 239000008103 glucose Substances 0.000 claims description 12
• 238000007918 intramuscular administration Methods 0.000 claims description 12
• 238000010255 intramuscular injection Methods 0.000 claims description 12
• 239000007927 intramuscular injection Substances 0.000 claims description 12
• 238000007912 intraperitoneal administration Methods 0.000 claims description 12
• 210000004185 liver Anatomy 0.000 claims description 12
• 238000007920 subcutaneous administration Methods 0.000 claims description 12
• 238000010254 subcutaneous injection Methods 0.000 claims description 12
• 239000007929 subcutaneous injection Substances 0.000 claims description 12
• 108020003589 5' Untranslated Regions Proteins 0.000 claims description 11
• 206010061218 Inflammation Diseases 0.000 claims description 11
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 11
• 241000700605 Viruses Species 0.000 claims description 11
• 102100030703 Interleukin-22 Human genes 0.000 claims description 10
• 108010071690 Prealbumin Proteins 0.000 claims description 10
• 102000009190 Transthyretin Human genes 0.000 claims description 10
• 201000011510 cancer Diseases 0.000 claims description 10
• 210000004207 dermis Anatomy 0.000 claims description 10
• 210000002615 epidermis Anatomy 0.000 claims description 10
• 238000011200 topical administration Methods 0.000 claims description 10
• 230000003442 weekly effect Effects 0.000 claims description 10
• 108010074109 interleukin-22 Proteins 0.000 claims description 9
• 230000009467 reduction Effects 0.000 claims description 9
• 108020005345 3' Untranslated Regions Proteins 0.000 claims description 8
• 102000009027 Albumins Human genes 0.000 claims description 8
• 108010088751 Albumins Proteins 0.000 claims description 8
• 208000007342 Diabetic Nephropathies Diseases 0.000 claims description 8
• 102000037982 Immune checkpoint proteins Human genes 0.000 claims description 8
• 208000002537 Neuronal Ceroid-Lipofuscinoses Diseases 0.000 claims description 8
• 101710089372 Programmed cell death protein 1 Proteins 0.000 claims description 8
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 8
• 208000033679 diabetic kidney disease Diseases 0.000 claims description 8
• 229940126546 immune checkpoint molecule Drugs 0.000 claims description 8
• 210000005229 liver cell Anatomy 0.000 claims description 8
• 239000008194 pharmaceutical composition Substances 0.000 claims description 8
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 8
• 210000002700 urine Anatomy 0.000 claims description 8
• 206010016654 Fibrosis Diseases 0.000 claims description 7
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine group Chemical group [C@@H]1([C@H](O)[C@H](O)[C@@H](CO)O1)N1C=NC=2C(N)=NC=NC12 OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 7
• 238000000338 in vitro Methods 0.000 claims description 7
• 208000017169 kidney disease Diseases 0.000 claims description 7
• 102100029492 Glycogen phosphorylase, muscle form Human genes 0.000 claims description 6
• 102100027685 Hemoglobin subunit alpha Human genes 0.000 claims description 6
• 108091005902 Hemoglobin subunit alpha Proteins 0.000 claims description 6
• 102100021519 Hemoglobin subunit beta Human genes 0.000 claims description 6
• 108091005904 Hemoglobin subunit beta Proteins 0.000 claims description 6
• 101000700475 Homo sapiens Glycogen phosphorylase, muscle form Proteins 0.000 claims description 6
• 101001116682 Homo sapiens Peroxisome assembly protein 26 Proteins 0.000 claims description 6
• 101001099372 Homo sapiens Peroxisome biogenesis factor 1 Proteins 0.000 claims description 6
• 206010020772 Hypertension Diseases 0.000 claims description 6
• 102000005327 Palmitoyl protein thioesterase Human genes 0.000 claims description 6
• 108020002591 Palmitoyl protein thioesterase Proteins 0.000 claims description 6
• 102100024925 Peroxisome assembly protein 26 Human genes 0.000 claims description 6
• 102100038881 Peroxisome biogenesis factor 1 Human genes 0.000 claims description 6
• 206010036182 Porphyria acute Diseases 0.000 claims description 6
• 208000010642 Porphyrias Diseases 0.000 claims description 6
• 201000004964 Rhizomelic Chondrodysplasia Punctata Diseases 0.000 claims description 6
• 238000009825 accumulation Methods 0.000 claims description 6
• DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 claims description 6
• 208000019425 cirrhosis of liver Diseases 0.000 claims description 6
• 208000007345 glycogen storage disease Diseases 0.000 claims description 6
• 230000001771 impaired effect Effects 0.000 claims description 6
• 210000001613 integumentary system Anatomy 0.000 claims description 6
• 230000035772 mutation Effects 0.000 claims description 6
• 208000008338 non-alcoholic fatty liver disease Diseases 0.000 claims description 6
• 206010053219 non-alcoholic steatohepatitis Diseases 0.000 claims description 6
• 230000002829 reductive effect Effects 0.000 claims description 6
• 230000035897 transcription Effects 0.000 claims description 6
• DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 claims description 6
• 229940045145 uridine Drugs 0.000 claims description 6
• 102100023990 60S ribosomal protein L17 Human genes 0.000 claims description 5
• 108091036407 Polyadenylation Proteins 0.000 claims description 5
• 208000006454 hepatitis Diseases 0.000 claims description 5
• 231100000283 hepatitis Toxicity 0.000 claims description 5
• 102100028734 1,4-alpha-glucan-branching enzyme Human genes 0.000 claims description 4
• 102100020775 Adenylosuccinate lyase Human genes 0.000 claims description 4
• 108700040193 Adenylosuccinate lyases Proteins 0.000 claims description 4
• 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 4
• 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 4
• 208000029751 Amino acid metabolism disease Diseases 0.000 claims description 4
• 208000034318 Argininemia Diseases 0.000 claims description 4
• 206010003658 Atrial Fibrillation Diseases 0.000 claims description 4
• 102100026189 Beta-galactosidase Human genes 0.000 claims description 4
• 208000024172 Cardiovascular disease Diseases 0.000 claims description 4
• 201000002929 Carnitine palmitoyltransferase II deficiency Diseases 0.000 claims description 4
• 102100034480 Ceroid-lipofuscinosis neuronal protein 6 Human genes 0.000 claims description 4
• 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 4
• 206010011224 Cough Diseases 0.000 claims description 4
• NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 claims description 4
• 102100040679 Dihydroxyacetone phosphate acyltransferase Human genes 0.000 claims description 4
• 208000035197 Disorder of carbohydrate metabolism Diseases 0.000 claims description 4
• 208000035968 Disorder of purine or pyrimidine metabolism Diseases 0.000 claims description 4
• 102100040068 E3 ubiquitin-protein ligase TRIM37 Human genes 0.000 claims description 4
• 102100030377 Endoplasmic reticulum metallopeptidase 1 Human genes 0.000 claims description 4
• 208000034846 Familial Amyloid Neuropathies Diseases 0.000 claims description 4
• 208000025499 G6PD deficiency Diseases 0.000 claims description 4
• 102100033495 Glycine dehydrogenase (decarboxylating), mitochondrial Human genes 0.000 claims description 4
• 102100029481 Glycogen phosphorylase, liver form Human genes 0.000 claims description 4
• 206010053185 Glycogen storage disease type II Diseases 0.000 claims description 4
• 206010019889 Hereditary neuropathic amyloidosis Diseases 0.000 claims description 4
• 101000765010 Homo sapiens Beta-galactosidase Proteins 0.000 claims description 4
• 101001039272 Homo sapiens Dihydroxyacetone phosphate acyltransferase Proteins 0.000 claims description 4
• 101000610400 Homo sapiens E3 ubiquitin-protein ligase TRIM37 Proteins 0.000 claims description 4
• 101001063315 Homo sapiens Endoplasmic reticulum metallopeptidase 1 Proteins 0.000 claims description 4
• 101001073025 Homo sapiens Peroxisomal targeting signal 1 receptor Proteins 0.000 claims description 4
• 101000693847 Homo sapiens Peroxisome biogenesis factor 2 Proteins 0.000 claims description 4
• 101000629622 Homo sapiens Serine-pyruvate aminotransferase Proteins 0.000 claims description 4
• 101000910482 Homo sapiens Uroporphyrinogen decarboxylase Proteins 0.000 claims description 4
• 208000008852 Hyperoxaluria Diseases 0.000 claims description 4
• 102100029107 Long chain 3-hydroxyacyl-CoA dehydrogenase Human genes 0.000 claims description 4
• 208000019693 Lung disease Diseases 0.000 claims description 4
• 208000032376 Lung infection Diseases 0.000 claims description 4
• 208000008955 Mucolipidoses Diseases 0.000 claims description 4
• 206010072927 Mucolipidosis type I Diseases 0.000 claims description 4
• 206010028289 Muscle atrophy Diseases 0.000 claims description 4
• 102100036598 Peroxisomal targeting signal 1 receptor Human genes 0.000 claims description 4
• 102100025516 Peroxisome biogenesis factor 2 Human genes 0.000 claims description 4
• 102100039421 Phytanoyl-CoA dioxygenase, peroxisomal Human genes 0.000 claims description 4
• 206010036186 Porphyria non-acute Diseases 0.000 claims description 4
• 208000016855 Porphyrin metabolism disease Diseases 0.000 claims description 4
• 108010076504 Protein Sorting Signals Proteins 0.000 claims description 4
• 206010062237 Renal impairment Diseases 0.000 claims description 4
• 241000725643 Respiratory syncytial virus Species 0.000 claims description 4
• 108091006161 SLC17A5 Proteins 0.000 claims description 4
• 102100026842 Serine-pyruvate aminotransferase Human genes 0.000 claims description 4
• 102100023105 Sialin Human genes 0.000 claims description 4
• 208000034972 Sudden Infant Death Diseases 0.000 claims description 4
• 206010042440 Sudden infant death syndrome Diseases 0.000 claims description 4
• 108010039203 Tripeptidyl-Peptidase 1 Proteins 0.000 claims description 4
• 102100034197 Tripeptidyl-peptidase 1 Human genes 0.000 claims description 4
• 102100024118 Uroporphyrinogen decarboxylase Human genes 0.000 claims description 4
• 208000017478 adult neuronal ceroid lipofuscinosis Diseases 0.000 claims description 4
• 210000002469 basement membrane Anatomy 0.000 claims description 4
• 230000008436 biogenesis Effects 0.000 claims description 4
• 208000020450 carbohydrate metabolism disease Diseases 0.000 claims description 4
• 208000013116 chronic cough Diseases 0.000 claims description 4
• 230000007882 cirrhosis Effects 0.000 claims description 4
• 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
• 229930195729 fatty acid Natural products 0.000 claims description 4
• 239000000194 fatty acid Substances 0.000 claims description 4
• 150000004665 fatty acids Chemical class 0.000 claims description 4
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical group O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims description 4
• 201000011286 hyperargininemia Diseases 0.000 claims description 4
• 210000002865 immune cell Anatomy 0.000 claims description 4
• 206010022000 influenza Diseases 0.000 claims description 4
• 208000016325 inherited fatty acid metabolism disease Diseases 0.000 claims description 4
• 230000003834 intracellular effect Effects 0.000 claims description 4
• 208000019423 liver disease Diseases 0.000 claims description 4
• 230000002132 lysosomal effect Effects 0.000 claims description 4
• 201000000585 muscular atrophy Diseases 0.000 claims description 4
• 201000007642 neuronal ceroid lipofuscinosis 1 Diseases 0.000 claims description 4
• 201000007607 neuronal ceroid lipofuscinosis 3 Diseases 0.000 claims description 4
• 201000007655 neuronal ceroid lipofuscinosis 6 Diseases 0.000 claims description 4
• 206010033675 panniculitis Diseases 0.000 claims description 4
• 210000002824 peroxisome Anatomy 0.000 claims description 4
• 231100000857 poor renal function Toxicity 0.000 claims description 4
• 230000018883 protein targeting Effects 0.000 claims description 4
• 230000028327 secretion Effects 0.000 claims description 4
• 238000003860 storage Methods 0.000 claims description 4
• 210000000438 stratum basale Anatomy 0.000 claims description 4
• 210000000434 stratum corneum Anatomy 0.000 claims description 4
• 210000000498 stratum granulosum Anatomy 0.000 claims description 4
• 210000000439 stratum lucidum Anatomy 0.000 claims description 4
• 210000000437 stratum spinosum Anatomy 0.000 claims description 4
• 201000007905 transthyretin amyloidosis Diseases 0.000 claims description 4
• 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 4
• 230000004143 urea cycle Effects 0.000 claims description 4
• 230000002792 vascular Effects 0.000 claims description 4
• 208000019553 vascular disease Diseases 0.000 claims description 4
• 108091035707 Consensus sequence Proteins 0.000 claims description 3
• 201000003883 Cystic fibrosis Diseases 0.000 claims description 3
• 206010022489 Insulin Resistance Diseases 0.000 claims description 3
• 108010017842 Telomerase Proteins 0.000 claims description 3
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 3
• 230000004761 fibrosis Effects 0.000 claims description 3
• 210000002216 heart Anatomy 0.000 claims description 3
• 208000019622 heart disease Diseases 0.000 claims description 3
• 238000003780 insertion Methods 0.000 claims description 3
• 230000037431 insertion Effects 0.000 claims description 3
• 230000003908 liver function Effects 0.000 claims description 3
• 238000004519 manufacturing process Methods 0.000 claims description 3
• 208000033939 neuronal 6A ceroid lipofuscinosis Diseases 0.000 claims description 3
• 208000011580 syndromic disease Diseases 0.000 claims description 3
• 108700032300 2,4-Dienoyl-CoA Reductase Deficiency Proteins 0.000 claims description 2
• 201000006753 2-hydroxyglutaric aciduria Diseases 0.000 claims description 2
• 102100035352 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial Human genes 0.000 claims description 2
• 102100035315 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial Human genes 0.000 claims description 2
• 108700028607 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency Proteins 0.000 claims description 2
• 108700005239 3-Hydroxyacyl-CoA Dehydrogenase Deficiency Proteins 0.000 claims description 2
• 208000024801 3-hydroxy-3-methylglutaric aciduria Diseases 0.000 claims description 2
• MXCVHSXCXPHOLP-UHFFFAOYSA-N 4-oxo-6-propylchromene-2-carboxylic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=CC(CCC)=CC=C21 MXCVHSXCXPHOLP-UHFFFAOYSA-N 0.000 claims description 2
• 101150012579 ADSL gene Proteins 0.000 claims description 2
• 102000010553 ALAD Human genes 0.000 claims description 2
• 101150082527 ALAD gene Proteins 0.000 claims description 2
• 102100032123 AMP deaminase 1 Human genes 0.000 claims description 2
• 102100024643 ATP-binding cassette sub-family D member 1 Human genes 0.000 claims description 2
• 102100024005 Acid ceramidase Human genes 0.000 claims description 2
• 208000013824 Acidemia Diseases 0.000 claims description 2
• 208000010444 Acidosis Diseases 0.000 claims description 2
• 208000004476 Acute Coronary Syndrome Diseases 0.000 claims description 2
• 208000009304 Acute Kidney Injury Diseases 0.000 claims description 2
• 208000005452 Acute intermittent porphyria Diseases 0.000 claims description 2
• 102000004539 Acyl-CoA Oxidase Human genes 0.000 claims description 2
• 108020001558 Acyl-CoA oxidase Proteins 0.000 claims description 2
• 206010072609 Adenine phosphoribosyl transferase deficiency Diseases 0.000 claims description 2
• 108010024223 Adenine phosphoribosyltransferase Proteins 0.000 claims description 2
• 102100029457 Adenine phosphoribosyltransferase Human genes 0.000 claims description 2
• 108700037006 Adenine phosphoribosyltransferase deficiency Proteins 0.000 claims description 2
• 102100036664 Adenosine deaminase Human genes 0.000 claims description 2
• 208000002016 Adenosine monophosphate deaminase deficiency Diseases 0.000 claims description 2
• 108700037035 Adenosine monophosphate deaminase deficiency Proteins 0.000 claims description 2
• 108700037034 Adenylosuccinate lyase deficiency Proteins 0.000 claims description 2
• 201000011452 Adrenoleukodystrophy Diseases 0.000 claims description 2
• 102100034112 Alkyldihydroxyacetonephosphate synthase, peroxisomal Human genes 0.000 claims description 2
• 102100035028 Alpha-L-iduronidase Human genes 0.000 claims description 2
• 208000029602 Alpha-N-acetylgalactosaminidase deficiency Diseases 0.000 claims description 2
• 102100034561 Alpha-N-acetylglucosaminidase Human genes 0.000 claims description 2
• 102100023165 Alpha-mannosidase 2C1 Human genes 0.000 claims description 2
• 208000031277 Amaurotic familial idiocy Diseases 0.000 claims description 2
• 102100039338 Aminomethyltransferase, mitochondrial Human genes 0.000 claims description 2
• 206010058298 Argininosuccinate synthetase deficiency Diseases 0.000 claims description 2
• 102100031491 Arylsulfatase B Human genes 0.000 claims description 2
• 208000033116 Asbestos intoxication Diseases 0.000 claims description 2
• 206010068220 Aspartylglucosaminuria Diseases 0.000 claims description 2
• 206010003591 Ataxia Diseases 0.000 claims description 2
• 201000001320 Atherosclerosis Diseases 0.000 claims description 2
• 208000023275 Autoimmune disease Diseases 0.000 claims description 2
• 108010074708 B7-H1 Antigen Proteins 0.000 claims description 2
• 102000008096 B7-H1 Antigen Human genes 0.000 claims description 2
• 241000894006 Bacteria Species 0.000 claims description 2
• 102100022440 Battenin Human genes 0.000 claims description 2
• 102100026031 Beta-glucuronidase Human genes 0.000 claims description 2
• 102100022549 Beta-hexosaminidase subunit beta Human genes 0.000 claims description 2
• 102100026044 Biotinidase Human genes 0.000 claims description 2
• 108010021064 CTLA-4 Antigen Proteins 0.000 claims description 2
• 102000008203 CTLA-4 Antigen Human genes 0.000 claims description 2
• 229940045513 CTLA4 antagonist Drugs 0.000 claims description 2
• 208000000970 Carbamoyl-Phosphate Synthase I Deficiency Disease Diseases 0.000 claims description 2
• 206010007509 Cardiac amyloidosis Diseases 0.000 claims description 2
• 208000031229 Cardiomyopathies Diseases 0.000 claims description 2
• 102100027943 Carnitine O-palmitoyltransferase 1, liver isoform Human genes 0.000 claims description 2
• 102100024853 Carnitine O-palmitoyltransferase 2, mitochondrial Human genes 0.000 claims description 2
• 208000005359 Carnitine palmitoyl transferase 1A deficiency Diseases 0.000 claims description 2
• 108700005857 Carnitine palmitoyl transferase 1A deficiency Proteins 0.000 claims description 2
• 108700005858 Carnitine palmitoyl transferase 2 deficiency Proteins 0.000 claims description 2
• 108700017419 Carnitine-Acylcarnitine Translocase Deficiency Proteins 0.000 claims description 2
• 102100032219 Cathepsin D Human genes 0.000 claims description 2
• 102100025953 Cathepsin F Human genes 0.000 claims description 2
• 102100024940 Cathepsin K Human genes 0.000 claims description 2
• 206010053684 Cerebrohepatorenal syndrome Diseases 0.000 claims description 2
• 102100034505 Ceroid-lipofuscinosis neuronal protein 5 Human genes 0.000 claims description 2
• 201000011297 Citrullinemia Diseases 0.000 claims description 2
• 102100023470 Cobalamin trafficking protein CblD Human genes 0.000 claims description 2
• 206010010099 Combined immunodeficiency Diseases 0.000 claims description 2
• 208000032170 Congenital Abnormalities Diseases 0.000 claims description 2
• 208000034958 Congenital erythropoietic porphyria Diseases 0.000 claims description 2
• 102100023376 Corrinoid adenosyltransferase Human genes 0.000 claims description 2
• 206010011416 Croup infectious Diseases 0.000 claims description 2
• 102100023381 Cyanocobalamin reductase / alkylcobalamin dealkylase Human genes 0.000 claims description 2
• 101710164985 Cyanocobalamin reductase / alkylcobalamin dealkylase Proteins 0.000 claims description 2
• 102100021430 Cyclic pyranopterin monophosphate synthase Human genes 0.000 claims description 2
• 206010011777 Cystinosis Diseases 0.000 claims description 2
• 206010011778 Cystinuria Diseases 0.000 claims description 2
• 101710186775 D-2-hydroxyglutarate dehydrogenase Proteins 0.000 claims description 2
• 102100025481 D-2-hydroxyglutarate dehydrogenase, mitochondrial Human genes 0.000 claims description 2
• 108010058076 D-xylulose reductase Proteins 0.000 claims description 2
• 208000011518 Danon disease Diseases 0.000 claims description 2
• 206010051055 Deep vein thrombosis Diseases 0.000 claims description 2
• 102100022283 Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial Human genes 0.000 claims description 2
• 101000797456 Dictyostelium discoideum AMP deaminase Proteins 0.000 claims description 2
• 102100023319 Dihydrolipoyl dehydrogenase, mitochondrial Human genes 0.000 claims description 2
• 108010052167 Dihydroorotate Dehydrogenase Proteins 0.000 claims description 2
• 102100032823 Dihydroorotate dehydrogenase (quinone), mitochondrial Human genes 0.000 claims description 2
• 201000010385 Dihydropyrimidine Dehydrogenase Deficiency Diseases 0.000 claims description 2
• 102100022334 Dihydropyrimidine dehydrogenase [NADP(+)] Human genes 0.000 claims description 2
• 102100031675 DnaJ homolog subfamily C member 5 Human genes 0.000 claims description 2
• 206010013887 Dysarthria Diseases 0.000 claims description 2
• 208000032928 Dyslipidaemia Diseases 0.000 claims description 2
• 102100030695 Electron transfer flavoprotein subunit alpha, mitochondrial Human genes 0.000 claims description 2
• 102100027262 Electron transfer flavoprotein subunit beta Human genes 0.000 claims description 2
• 102100031804 Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial Human genes 0.000 claims description 2
• 206010014561 Emphysema Diseases 0.000 claims description 2
• 102100023164 Epididymis-specific alpha-mannosidase Human genes 0.000 claims description 2
• 208000007209 Erythropoietic Porphyria Diseases 0.000 claims description 2
• 102100027186 Extracellular superoxide dismutase [Cu-Zn] Human genes 0.000 claims description 2
• 208000024720 Fabry Disease Diseases 0.000 claims description 2
• 208000001948 Farber Lipogranulomatosis Diseases 0.000 claims description 2
• 208000033149 Farber disease Diseases 0.000 claims description 2
• 208000004930 Fatty Liver Diseases 0.000 claims description 2
• 102100030771 Ferrochelatase, mitochondrial Human genes 0.000 claims description 2
• 206010061159 Foot deformity Diseases 0.000 claims description 2
• 102100028875 Formylglycine-generating enzyme Human genes 0.000 claims description 2
• 206010072104 Fructose intolerance Diseases 0.000 claims description 2
• 108010017464 Fructose-Bisphosphatase Proteins 0.000 claims description 2
• 102000027487 Fructose-Bisphosphatase Human genes 0.000 claims description 2
• 102100022277 Fructose-bisphosphate aldolase A Human genes 0.000 claims description 2
• 102100022272 Fructose-bisphosphate aldolase B Human genes 0.000 claims description 2
• 241000233866 Fungi Species 0.000 claims description 2
• 201000008892 GM1 Gangliosidosis Diseases 0.000 claims description 2
• 201000008232 GM2 gangliosidosis, AB variant Diseases 0.000 claims description 2
• 102100028496 Galactocerebrosidase Human genes 0.000 claims description 2
• 102100037777 Galactokinase Human genes 0.000 claims description 2
• 208000027472 Galactosemias Diseases 0.000 claims description 2
• 208000017462 Galactosialidosis Diseases 0.000 claims description 2
• 102100023364 Ganglioside GM2 activator Human genes 0.000 claims description 2
• 208000015872 Gaucher disease Diseases 0.000 claims description 2
• 208000010055 Globoid Cell Leukodystrophy Diseases 0.000 claims description 2
• 102100036264 Glucose-6-phosphatase catalytic subunit 1 Human genes 0.000 claims description 2
• 102100035172 Glucose-6-phosphate 1-dehydrogenase Human genes 0.000 claims description 2
• 206010018444 Glucose-6-phosphate dehydrogenase deficiency Diseases 0.000 claims description 2
• 102100025506 Glycine cleavage system H protein, mitochondrial Human genes 0.000 claims description 2
• 208000001500 Glycogen Storage Disease Type IIb Diseases 0.000 claims description 2
• 206010053249 Glycogen Storage Disease Type IV Diseases 0.000 claims description 2
• 208000006562 Glycogen Storage Disease Type VII Diseases 0.000 claims description 2
• 102100039264 Glycogen [starch] synthase, liver Human genes 0.000 claims description 2
• 102100039262 Glycogen [starch] synthase, muscle Human genes 0.000 claims description 2
• 208000035148 Glycogen storage disease due to LAMP-2 deficiency Diseases 0.000 claims description 2
• 208000032007 Glycogen storage disease due to acid maltase deficiency Diseases 0.000 claims description 2
• 208000032003 Glycogen storage disease due to glucose-6-phosphatase deficiency Diseases 0.000 claims description 2
• 208000011123 Glycogen storage disease due to glycogen branching enzyme deficiency Diseases 0.000 claims description 2
• 208000032008 Glycogen storage disease due to glycogen debranching enzyme deficiency Diseases 0.000 claims description 2
• 208000032002 Glycogen storage disease due to liver glycogen phosphorylase deficiency Diseases 0.000 claims description 2
• 208000032000 Glycogen storage disease due to muscle glycogen phosphorylase deficiency Diseases 0.000 claims description 2
• 208000031926 Glycogen storage disease due to muscle phosphofructokinase deficiency Diseases 0.000 claims description 2
• 208000014324 Glycogen storage disease due to phosphorylase kinase deficiency Diseases 0.000 claims description 2
• 206010018464 Glycogen storage disease type I Diseases 0.000 claims description 2
• 206010053250 Glycogen storage disease type III Diseases 0.000 claims description 2
• 206010018462 Glycogen storage disease type V Diseases 0.000 claims description 2
• 206010053240 Glycogen storage disease type VI Diseases 0.000 claims description 2
• 102100030648 Glyoxylate reductase/hydroxypyruvate reductase Human genes 0.000 claims description 2
• 208000012777 Hartnup Disease Diseases 0.000 claims description 2
• 206010019280 Heart failures Diseases 0.000 claims description 2
• 102100039991 Heparan-alpha-glucosaminide N-acetyltransferase Human genes 0.000 claims description 2
• 206010019663 Hepatic failure Diseases 0.000 claims description 2
• 206010019708 Hepatic steatosis Diseases 0.000 claims description 2
• 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims description 2
• 208000003591 Hepatoerythropoietic Porphyria Diseases 0.000 claims description 2
• 206010019842 Hepatomegaly Diseases 0.000 claims description 2
• 208000000627 Hereditary Coproporphyria Diseases 0.000 claims description 2
• 206010019878 Hereditary fructose intolerance Diseases 0.000 claims description 2
• 102000005548 Hexokinase Human genes 0.000 claims description 2
• 108700040460 Hexokinases Proteins 0.000 claims description 2
• 101001058479 Homo sapiens 1,4-alpha-glucan-branching enzyme Proteins 0.000 claims description 2
• 101000597665 Homo sapiens 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial Proteins 0.000 claims description 2
• 101000597680 Homo sapiens 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial Proteins 0.000 claims description 2
• 101000775844 Homo sapiens AMP deaminase 1 Proteins 0.000 claims description 2
• 101000975753 Homo sapiens Acid ceramidase Proteins 0.000 claims description 2
• 101000799143 Homo sapiens Alkyldihydroxyacetonephosphate synthase, peroxisomal Proteins 0.000 claims description 2
• 101001019502 Homo sapiens Alpha-L-iduronidase Proteins 0.000 claims description 2
• 101000979029 Homo sapiens Alpha-mannosidase 2C1 Proteins 0.000 claims description 2
• 101000887804 Homo sapiens Aminomethyltransferase, mitochondrial Proteins 0.000 claims description 2
• 101000923070 Homo sapiens Arylsulfatase B Proteins 0.000 claims description 2
• 101000933465 Homo sapiens Beta-glucuronidase Proteins 0.000 claims description 2
• 101001045433 Homo sapiens Beta-hexosaminidase subunit beta Proteins 0.000 claims description 2
• 101000859570 Homo sapiens Carnitine O-palmitoyltransferase 1, liver isoform Proteins 0.000 claims description 2
• 101000869010 Homo sapiens Cathepsin D Proteins 0.000 claims description 2
• 101000933218 Homo sapiens Cathepsin F Proteins 0.000 claims description 2
• 101000761509 Homo sapiens Cathepsin K Proteins 0.000 claims description 2
• 101000977167 Homo sapiens Cobalamin trafficking protein CblD Proteins 0.000 claims description 2
• 101001114650 Homo sapiens Corrinoid adenosyltransferase Proteins 0.000 claims description 2
• 101000969676 Homo sapiens Cyclic pyranopterin monophosphate synthase Proteins 0.000 claims description 2
• 101000755868 Homo sapiens Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial Proteins 0.000 claims description 2
• 101000902632 Homo sapiens Dihydropyrimidine dehydrogenase [NADP(+)] Proteins 0.000 claims description 2
• 101000845893 Homo sapiens DnaJ homolog subfamily C member 5 Proteins 0.000 claims description 2
• 101001010541 Homo sapiens Electron transfer flavoprotein subunit alpha, mitochondrial Proteins 0.000 claims description 2
• 101001057122 Homo sapiens Electron transfer flavoprotein subunit beta Proteins 0.000 claims description 2
• 101000920874 Homo sapiens Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial Proteins 0.000 claims description 2
• 101000979031 Homo sapiens Epididymis-specific alpha-mannosidase Proteins 0.000 claims description 2
• 101000836222 Homo sapiens Extracellular superoxide dismutase [Cu-Zn] Proteins 0.000 claims description 2
• 101000843611 Homo sapiens Ferrochelatase, mitochondrial Proteins 0.000 claims description 2
• 101000648611 Homo sapiens Formylglycine-generating enzyme Proteins 0.000 claims description 2
• 101000755879 Homo sapiens Fructose-bisphosphate aldolase A Proteins 0.000 claims description 2
• 101000755933 Homo sapiens Fructose-bisphosphate aldolase B Proteins 0.000 claims description 2
• 101000860395 Homo sapiens Galactocerebrosidase Proteins 0.000 claims description 2
• 101001024874 Homo sapiens Galactokinase Proteins 0.000 claims description 2
• 101000685969 Homo sapiens Ganglioside GM2 activator Proteins 0.000 claims description 2
• 101000930910 Homo sapiens Glucose-6-phosphatase catalytic subunit 1 Proteins 0.000 claims description 2
• 101000856845 Homo sapiens Glycine cleavage system H protein, mitochondrial Proteins 0.000 claims description 2
• 101000998096 Homo sapiens Glycine dehydrogenase (decarboxylating), mitochondrial Proteins 0.000 claims description 2
• 101001036117 Homo sapiens Glycogen [starch] synthase, liver Proteins 0.000 claims description 2
• 101001036130 Homo sapiens Glycogen [starch] synthase, muscle Proteins 0.000 claims description 2
• 101000700616 Homo sapiens Glycogen phosphorylase, liver form Proteins 0.000 claims description 2
• 101001010442 Homo sapiens Glyoxylate reductase/hydroxypyruvate reductase Proteins 0.000 claims description 2
• 101001035092 Homo sapiens Heparan-alpha-glucosaminide N-acetyltransferase Proteins 0.000 claims description 2
• 101001068133 Homo sapiens Hepatitis A virus cellular receptor 2 Proteins 0.000 claims description 2
• 101001083553 Homo sapiens Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial Proteins 0.000 claims description 2
• 101001047912 Homo sapiens Hydroxymethylglutaryl-CoA lyase, mitochondrial Proteins 0.000 claims description 2
• 101001138081 Homo sapiens L-2-hydroxyglutarate dehydrogenase, mitochondrial Proteins 0.000 claims description 2
• 101001122174 Homo sapiens Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial Proteins 0.000 claims description 2
• 101000841267 Homo sapiens Long chain 3-hydroxyacyl-CoA dehydrogenase Proteins 0.000 claims description 2
• 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 claims description 2
• 101000979046 Homo sapiens Lysosomal alpha-mannosidase Proteins 0.000 claims description 2
• 101001122938 Homo sapiens Lysosomal protective protein Proteins 0.000 claims description 2
• 101000575454 Homo sapiens Major facilitator superfamily domain-containing protein 8 Proteins 0.000 claims description 2
• 101000918777 Homo sapiens Malonyl-CoA decarboxylase, mitochondrial Proteins 0.000 claims description 2
• 101000760730 Homo sapiens Medium-chain specific acyl-CoA dehydrogenase, mitochondrial Proteins 0.000 claims description 2
• 101000587058 Homo sapiens Methylenetetrahydrofolate reductase Proteins 0.000 claims description 2
• 101001114654 Homo sapiens Methylmalonic aciduria type A protein, mitochondrial Proteins 0.000 claims description 2
• 101001018470 Homo sapiens Methylmalonyl-CoA epimerase, mitochondrial Proteins 0.000 claims description 2
• 101001126977 Homo sapiens Methylmalonyl-CoA mutase, mitochondrial Proteins 0.000 claims description 2
• 101000591936 Homo sapiens Molybdopterin synthase catalytic subunit Proteins 0.000 claims description 2
• 101000963255 Homo sapiens Molybdopterin synthase sulfur carrier subunit Proteins 0.000 claims description 2
• 101001066305 Homo sapiens N-acetylgalactosamine-6-sulfatase Proteins 0.000 claims description 2
• 101001072477 Homo sapiens N-acetylglucosamine-1-phosphotransferase subunit gamma Proteins 0.000 claims description 2
• 101001072470 Homo sapiens N-acetylglucosamine-1-phosphotransferase subunits alpha/beta Proteins 0.000 claims description 2
• 101000829992 Homo sapiens N-acetylglucosamine-6-sulfatase Proteins 0.000 claims description 2
• 101000651201 Homo sapiens N-sulphoglucosamine sulphohydrolase Proteins 0.000 claims description 2
• 101000589671 Homo sapiens NAD kinase 2, mitochondrial Proteins 0.000 claims description 2
• 101000833892 Homo sapiens Peroxisomal acyl-coenzyme A oxidase 1 Proteins 0.000 claims description 2
• 101000987700 Homo sapiens Peroxisomal biogenesis factor 3 Proteins 0.000 claims description 2
• 101000579352 Homo sapiens Peroxisomal membrane protein PEX13 Proteins 0.000 claims description 2
• 101000600178 Homo sapiens Peroxisomal membrane protein PEX14 Proteins 0.000 claims description 2
• 101001045218 Homo sapiens Peroxisomal multifunctional enzyme type 2 Proteins 0.000 claims description 2
• 101000730779 Homo sapiens Peroxisome assembly factor 2 Proteins 0.000 claims description 2
• 101000579342 Homo sapiens Peroxisome assembly protein 12 Proteins 0.000 claims description 2
• 101001126498 Homo sapiens Peroxisome biogenesis factor 10 Proteins 0.000 claims description 2
• 101000731078 Homo sapiens Phosphorylase b kinase gamma catalytic chain, liver/testis isoform Proteins 0.000 claims description 2
• 101001126783 Homo sapiens Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform Proteins 0.000 claims description 2
• 101000945272 Homo sapiens Phosphorylase b kinase regulatory subunit alpha, liver isoform Proteins 0.000 claims description 2
• 101000945267 Homo sapiens Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform Proteins 0.000 claims description 2
• 101001137939 Homo sapiens Phosphorylase b kinase regulatory subunit beta Proteins 0.000 claims description 2
• 101000609253 Homo sapiens Phytanoyl-CoA dioxygenase, peroxisomal Proteins 0.000 claims description 2
• 101001098982 Homo sapiens Propionyl-CoA carboxylase beta chain, mitochondrial Proteins 0.000 claims description 2
• 101001091536 Homo sapiens Pyruvate kinase PKLR Proteins 0.000 claims description 2
• 101000724404 Homo sapiens Saccharopine dehydrogenase Proteins 0.000 claims description 2
• 101000760716 Homo sapiens Short-chain specific acyl-CoA dehydrogenase, mitochondrial Proteins 0.000 claims description 2
• 101001123859 Homo sapiens Sialidase-1 Proteins 0.000 claims description 2
• 101001123851 Homo sapiens Sialidase-2 Proteins 0.000 claims description 2
• 101001123847 Homo sapiens Sialidase-3 Proteins 0.000 claims description 2
• 101000601384 Homo sapiens Sialidase-4 Proteins 0.000 claims description 2
• 101000785978 Homo sapiens Sphingomyelin phosphodiesterase Proteins 0.000 claims description 2
• 101000893741 Homo sapiens Tissue alpha-L-fucosidase Proteins 0.000 claims description 2
• 101000801742 Homo sapiens Triosephosphate isomerase Proteins 0.000 claims description 2
• 206010020365 Homocystinuria Diseases 0.000 claims description 2
• 208000015178 Hurler syndrome Diseases 0.000 claims description 2
• 102100024004 Hydroxymethylglutaryl-CoA lyase, mitochondrial Human genes 0.000 claims description 2
• 208000035150 Hypercholesterolemia Diseases 0.000 claims description 2
• 208000033892 Hyperhomocysteinemia Diseases 0.000 claims description 2
• 206010060378 Hyperinsulinaemia Diseases 0.000 claims description 2
• 108700022128 Hypermethioninemia Proteins 0.000 claims description 2
• 206010058222 Hypertensive cardiomyopathy Diseases 0.000 claims description 2
• 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 claims description 2
• 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 claims description 2
• 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims description 2
• 208000008498 Infantile Refsum disease Diseases 0.000 claims description 2
• 208000000420 Isovaleric acidemia Diseases 0.000 claims description 2
• 206010023126 Jaundice Diseases 0.000 claims description 2
• 206010023421 Kidney fibrosis Diseases 0.000 claims description 2
• 208000028226 Krabbe disease Diseases 0.000 claims description 2
• 102100020920 L-2-hydroxyglutarate dehydrogenase, mitochondrial Human genes 0.000 claims description 2
• 102000017578 LAG3 Human genes 0.000 claims description 2
• 208000017170 Lipid metabolism disease Diseases 0.000 claims description 2
• 102100027064 Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial Human genes 0.000 claims description 2
• 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 2
• 208000003221 Lysosomal acid lipase deficiency Diseases 0.000 claims description 2
• 102100026001 Lysosomal acid lipase/cholesteryl ester hydrolase Human genes 0.000 claims description 2
• 102100023231 Lysosomal alpha-mannosidase Human genes 0.000 claims description 2
• 102100028524 Lysosomal protective protein Human genes 0.000 claims description 2
• 108010009491 Lysosomal-Associated Membrane Protein 2 Proteins 0.000 claims description 2
• 102100038225 Lysosome-associated membrane glycoprotein 2 Human genes 0.000 claims description 2
• 102000003624 MCOLN1 Human genes 0.000 claims description 2
• 101150091161 MCOLN1 gene Proteins 0.000 claims description 2
• 102100025613 Major facilitator superfamily domain-containing protein 8 Human genes 0.000 claims description 2
• 108700004450 Malonic aciduria Proteins 0.000 claims description 2
• 208000003160 Malonic aciduria Diseases 0.000 claims description 2
• 102100029461 Malonyl-CoA decarboxylase, mitochondrial Human genes 0.000 claims description 2
• 208000030162 Maple syrup disease Diseases 0.000 claims description 2
• 108700000232 Medium chain acyl CoA dehydrogenase deficiency Proteins 0.000 claims description 2
• 206010072654 Medium-chain acyl-coenzyme A dehydrogenase deficiency Diseases 0.000 claims description 2
• 102100024590 Medium-chain specific acyl-CoA dehydrogenase, mitochondrial Human genes 0.000 claims description 2
• 108010049137 Member 1 Subfamily D ATP Binding Cassette Transporter Proteins 0.000 claims description 2
• 201000011442 Metachromatic leukodystrophy Diseases 0.000 claims description 2
• 102100029684 Methylenetetrahydrofolate reductase Human genes 0.000 claims description 2
• 102100023377 Methylmalonic aciduria type A protein, mitochondrial Human genes 0.000 claims description 2
• 102100033712 Methylmalonyl-CoA epimerase, mitochondrial Human genes 0.000 claims description 2
• 102100030979 Methylmalonyl-CoA mutase, mitochondrial Human genes 0.000 claims description 2
• 102100038738 Mitochondrial carnitine/acylcarnitine carrier protein Human genes 0.000 claims description 2
• 102100039428 Molybdopterin synthase sulfur carrier subunit Human genes 0.000 claims description 2
• 206010072930 Mucolipidosis type IV Diseases 0.000 claims description 2
• 102100026502 Mucolipin-1 Human genes 0.000 claims description 2
• 206010056886 Mucopolysaccharidosis I Diseases 0.000 claims description 2
• 206010028095 Mucopolysaccharidosis IV Diseases 0.000 claims description 2
• 206010056893 Mucopolysaccharidosis VII Diseases 0.000 claims description 2
• 201000006054 Mulibrey nanism Diseases 0.000 claims description 2
• 208000000149 Multiple Sulfatase Deficiency Disease Diseases 0.000 claims description 2
• 208000035032 Multiple sulfatase deficiency Diseases 0.000 claims description 2
• 101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 claims description 2
• 208000010428 Muscle Weakness Diseases 0.000 claims description 2
• 206010028372 Muscular weakness Diseases 0.000 claims description 2
• 201000002481 Myositis Diseases 0.000 claims description 2
• 108700043217 N-acetyl glutamate synthetase deficiency Proteins 0.000 claims description 2
• 102100031688 N-acetylgalactosamine-6-sulfatase Human genes 0.000 claims description 2
• 102100036713 N-acetylglucosamine-1-phosphotransferase subunit gamma Human genes 0.000 claims description 2
• 102100036710 N-acetylglucosamine-1-phosphotransferase subunits alpha/beta Human genes 0.000 claims description 2
• 102100023282 N-acetylglucosamine-6-sulfatase Human genes 0.000 claims description 2
• 206010071092 N-acetylglutamate synthase deficiency Diseases 0.000 claims description 2
• 102100032618 N-acetylglutamate synthase, mitochondrial Human genes 0.000 claims description 2
• 102100027661 N-sulphoglucosamine sulphohydrolase Human genes 0.000 claims description 2
• 102100032217 NAD kinase 2, mitochondrial Human genes 0.000 claims description 2
• 208000018909 Neonatal adrenoleukodystrophy Diseases 0.000 claims description 2
• 102100027341 Neutral and basic amino acid transport protein rBAT Human genes 0.000 claims description 2
• 208000035544 Nonketotic hyperglycinaemia Diseases 0.000 claims description 2
• 208000008589 Obesity Diseases 0.000 claims description 2
• 208000000599 Ornithine Carbamoyltransferase Deficiency Disease Diseases 0.000 claims description 2
• 206010052450 Ornithine transcarbamoylase deficiency Diseases 0.000 claims description 2
• 208000035903 Ornithine transcarbamylase deficiency Diseases 0.000 claims description 2
• 201000002892 Oroticaciduria Diseases 0.000 claims description 2
• 241000150452 Orthohantavirus Species 0.000 claims description 2
• 101150096217 PHYH gene Proteins 0.000 claims description 2
• 102100025824 Palmitoyl-protein thioesterase 1 Human genes 0.000 claims description 2
• 108010077056 Peroxisomal Targeting Signal 2 Receptor Proteins 0.000 claims description 2
• 102100026798 Peroxisomal acyl-coenzyme A oxidase 1 Human genes 0.000 claims description 2
• 102100029577 Peroxisomal biogenesis factor 3 Human genes 0.000 claims description 2
• 208000020547 Peroxisomal disease Diseases 0.000 claims description 2
• 102100028223 Peroxisomal membrane protein PEX13 Human genes 0.000 claims description 2
• 102100037476 Peroxisomal membrane protein PEX14 Human genes 0.000 claims description 2
• 102100022587 Peroxisomal multifunctional enzyme type 2 Human genes 0.000 claims description 2
• 102100032924 Peroxisomal targeting signal 2 receptor Human genes 0.000 claims description 2
• 102100032931 Peroxisome assembly factor 2 Human genes 0.000 claims description 2
• 102100028224 Peroxisome assembly protein 12 Human genes 0.000 claims description 2
• 102100030554 Peroxisome biogenesis factor 10 Human genes 0.000 claims description 2
• 201000005702 Pertussis Diseases 0.000 claims description 2
• 102100032391 Phosphorylase b kinase gamma catalytic chain, liver/testis isoform Human genes 0.000 claims description 2
• 102100030278 Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform Human genes 0.000 claims description 2
• 102100033548 Phosphorylase b kinase regulatory subunit alpha, liver isoform Human genes 0.000 claims description 2
• 102100033547 Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform Human genes 0.000 claims description 2
• 102100020854 Phosphorylase b kinase regulatory subunit beta Human genes 0.000 claims description 2
• 206010035226 Plasma cell myeloma Diseases 0.000 claims description 2
• 206010035664 Pneumonia Diseases 0.000 claims description 2
• 101710189720 Porphobilinogen deaminase Proteins 0.000 claims description 2
• 102100034391 Porphobilinogen deaminase Human genes 0.000 claims description 2
• 101710170827 Porphobilinogen deaminase, chloroplastic Proteins 0.000 claims description 2
• 108010072970 Porphobilinogen synthase Proteins 0.000 claims description 2
• 241000097929 Porphyria Species 0.000 claims description 2
• 201000010273 Porphyria Cutanea Tarda Diseases 0.000 claims description 2
• 208000033141 Porphyria variegata Diseases 0.000 claims description 2
• 208000030464 Postaxial acrofacial dysostosis Diseases 0.000 claims description 2
• 101710119292 Probable D-lactate dehydrogenase, mitochondrial Proteins 0.000 claims description 2
• 101710100896 Probable porphobilinogen deaminase Proteins 0.000 claims description 2
• 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 claims description 2
• 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 claims description 2
• 208000028269 Progressive encephalopathy with leukodystrophy due to DECR deficiency Diseases 0.000 claims description 2
• 102100028772 Proline dehydrogenase 1, mitochondrial Human genes 0.000 claims description 2
• 102100039025 Propionyl-CoA carboxylase beta chain, mitochondrial Human genes 0.000 claims description 2
• 102100034479 Protein CLN8 Human genes 0.000 claims description 2
• 102100029028 Protoporphyrinogen oxidase Human genes 0.000 claims description 2
• 208000010378 Pulmonary Embolism Diseases 0.000 claims description 2
• 108010007100 Pulmonary Surfactant-Associated Protein A Proteins 0.000 claims description 2
• 102100027773 Pulmonary surfactant-associated protein A2 Human genes 0.000 claims description 2
• 108700017801 Purine Nucleoside Phosphorylase Deficiency Proteins 0.000 claims description 2
• 108700014121 Pyruvate Kinase Deficiency of Red Cells Proteins 0.000 claims description 2
• 208000021886 Pyruvate carboxylase deficiency Diseases 0.000 claims description 2
• 102100034909 Pyruvate kinase PKLR Human genes 0.000 claims description 2
• 102000004879 Racemases and epimerases Human genes 0.000 claims description 2
• 108090001066 Racemases and epimerases Proteins 0.000 claims description 2
• 208000005587 Refsum Disease Diseases 0.000 claims description 2
• 208000001647 Renal Insufficiency Diseases 0.000 claims description 2
• 208000033626 Renal failure acute Diseases 0.000 claims description 2
• 201000008536 Rhizomelic chondrodysplasia punctata type 2 Diseases 0.000 claims description 2
• 108091006157 SLC17A3 Proteins 0.000 claims description 2
• 108091006736 SLC22A5 Proteins 0.000 claims description 2
• 108091006422 SLC25A20 Proteins 0.000 claims description 2
• 108091006299 SLC2A2 Proteins 0.000 claims description 2
• 108091006311 SLC3A1 Proteins 0.000 claims description 2
• 108091006277 SLC5A1 Proteins 0.000 claims description 2
• 108060007758 SLC6A19 Proteins 0.000 claims description 2
• 102000005025 SLC6A19 Human genes 0.000 claims description 2
• 108091006239 SLC7A9 Proteins 0.000 claims description 2
• 102100028294 Saccharopine dehydrogenase Human genes 0.000 claims description 2
• 208000021811 Sandhoff disease Diseases 0.000 claims description 2
• 206010040047 Sepsis Diseases 0.000 claims description 2
• 108700017825 Short chain Acyl CoA dehydrogenase deficiency Proteins 0.000 claims description 2
• 206010072655 Short-chain acyl-coenzyme A dehydrogenase deficiency Diseases 0.000 claims description 2
• 102100024639 Short-chain specific acyl-CoA dehydrogenase, mitochondrial Human genes 0.000 claims description 2
• 102100028760 Sialidase-1 Human genes 0.000 claims description 2
• 102100028755 Sialidase-2 Human genes 0.000 claims description 2
• 102100028756 Sialidase-3 Human genes 0.000 claims description 2
• 102100037729 Sialidase-4 Human genes 0.000 claims description 2
• 206010072170 Skin wound Diseases 0.000 claims description 2
• 201000001828 Sly syndrome Diseases 0.000 claims description 2
• 102000058090 Sodium-Glucose Transporter 1 Human genes 0.000 claims description 2
• 102100038439 Sodium-dependent phosphate transport protein 4 Human genes 0.000 claims description 2
• 102100023537 Solute carrier family 2, facilitated glucose transporter member 2 Human genes 0.000 claims description 2
• 102100036924 Solute carrier family 22 member 5 Human genes 0.000 claims description 2
• 102100026974 Sorbitol dehydrogenase Human genes 0.000 claims description 2
• 102100026263 Sphingomyelin phosphodiesterase Human genes 0.000 claims description 2
• 208000033897 Systemic primary carnitine deficiency Diseases 0.000 claims description 2
• 208000008206 Talipes Cavus Diseases 0.000 claims description 2
• 208000007536 Thrombosis Diseases 0.000 claims description 2
• 102100040526 Tissue alpha-L-fucosidase Human genes 0.000 claims description 2
• 108700037018 Transaldolase Deficiency Proteins 0.000 claims description 2
• 208000002706 Transaldolase deficiency Diseases 0.000 claims description 2
• 108700036262 Trifunctional Protein Deficiency With Myopathy And Neuropathy Proteins 0.000 claims description 2
• 206010068233 Trimethylaminuria Diseases 0.000 claims description 2
• 201000003399 Triose phosphate-isomerase deficiency Diseases 0.000 claims description 2
• 108700034122 Triosephosphate Isomerase Deficiency Proteins 0.000 claims description 2
• 102100033598 Triosephosphate isomerase Human genes 0.000 claims description 2
• 108700001567 Type I Schindler Disease Proteins 0.000 claims description 2
• 108020000963 Uroporphyrinogen-III synthase Proteins 0.000 claims description 2
• 102100034397 Uroporphyrinogen-III synthase Human genes 0.000 claims description 2
• 206010046996 Varicose vein Diseases 0.000 claims description 2
• 201000011053 Variegate Porphyria Diseases 0.000 claims description 2
• 206010047249 Venous thrombosis Diseases 0.000 claims description 2
• 206010047295 Ventricular hypertrophy Diseases 0.000 claims description 2
• 206010072656 Very long-chain acyl-coenzyme A dehydrogenase deficiency Diseases 0.000 claims description 2
• 208000010796 X-linked adrenoleukodystrophy Diseases 0.000 claims description 2
• 201000004525 Zellweger Syndrome Diseases 0.000 claims description 2
• 208000036813 Zellweger spectrum disease Diseases 0.000 claims description 2
• BOPGDPNILDQYTO-NDOGXIPWSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2r,3r,4r,5r)-5-(3-carbamoyl-4h-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NDOGXIPWSA-N 0.000 claims description 2
• 208000002223 abdominal aortic aneurysm Diseases 0.000 claims description 2
• 208000003486 acatalasia Diseases 0.000 claims description 2
• 201000011040 acute kidney failure Diseases 0.000 claims description 2
• 206010000891 acute myocardial infarction Diseases 0.000 claims description 2
• 201000009628 adenosine deaminase deficiency Diseases 0.000 claims description 2
• 208000000391 adenylosuccinate lyase deficiency Diseases 0.000 claims description 2
• 208000030597 adult Refsum disease Diseases 0.000 claims description 2
• 230000001476 alcoholic effect Effects 0.000 claims description 2
• 206010001689 alkaptonuria Diseases 0.000 claims description 2
• 108010009380 alpha-N-acetyl-D-glucosaminidase Proteins 0.000 claims description 2
• 201000008333 alpha-mannosidosis Diseases 0.000 claims description 2
• 206010002022 amyloidosis Diseases 0.000 claims description 2
• 208000007474 aortic aneurysm Diseases 0.000 claims description 2
• 201000003554 argininosuccinic aciduria Diseases 0.000 claims description 2
• 206010003441 asbestosis Diseases 0.000 claims description 2
• 208000006673 asthma Diseases 0.000 claims description 2
• 206010003668 atrial tachycardia Diseases 0.000 claims description 2
• 208000036556 autosomal recessive T cell-negative B cell-negative NK cell-negative due to adenosine deaminase deficiency severe combined immunodeficiency Diseases 0.000 claims description 2
• 102100021298 b(0,+)-type amino acid transporter 1 Human genes 0.000 claims description 2
• 201000006486 beta-mannosidosis Diseases 0.000 claims description 2
• 206010071434 biotinidase deficiency Diseases 0.000 claims description 2
• 201000009267 bronchiectasis Diseases 0.000 claims description 2
• 206010006451 bronchitis Diseases 0.000 claims description 2
• 201000004010 carnitine palmitoyltransferase I deficiency Diseases 0.000 claims description 2
• 208000005071 carnitine-acylcarnitine translocase deficiency Diseases 0.000 claims description 2
• 125000002091 cationic group Chemical group 0.000 claims description 2
• 208000029078 coronary artery disease Diseases 0.000 claims description 2
• 201000010549 croup Diseases 0.000 claims description 2
• 201000008230 cutaneous porphyria Diseases 0.000 claims description 2
• 201000003332 d-bifunctional protein deficiency Diseases 0.000 claims description 2
• 230000006735 deficit Effects 0.000 claims description 2
• 206010012601 diabetes mellitus Diseases 0.000 claims description 2
• 208000000759 dicarboxylic aminoaciduria Diseases 0.000 claims description 2
• 208000022837 disorder of methionine catabolism Diseases 0.000 claims description 2
• 201000008220 erythropoietic protoporphyria Diseases 0.000 claims description 2
• 206010015487 essential fructosuria Diseases 0.000 claims description 2
• 230000004438 eyesight Effects 0.000 claims description 2
• 208000010706 fatty liver disease Diseases 0.000 claims description 2
• 201000008049 fucosidosis Diseases 0.000 claims description 2
• 208000005594 glucose-galactose malabsorption Diseases 0.000 claims description 2
• 208000008605 glucosephosphate dehydrogenase deficiency Diseases 0.000 claims description 2
• 201000011205 glycine encephalopathy Diseases 0.000 claims description 2
• 201000004541 glycogen storage disease I Diseases 0.000 claims description 2
• 201000004502 glycogen storage disease II Diseases 0.000 claims description 2
• 201000004543 glycogen storage disease III Diseases 0.000 claims description 2
• 201000004534 glycogen storage disease V Diseases 0.000 claims description 2
• 201000004510 glycogen storage disease VI Diseases 0.000 claims description 2
• 201000009339 glycogen storage disease VII Diseases 0.000 claims description 2
• 208000023103 glycogen storage disease due to aldolase A deficiency Diseases 0.000 claims description 2
• 201000008977 glycoproteinosis Diseases 0.000 claims description 2
• 208000016354 hearing loss disease Diseases 0.000 claims description 2
• 101150055960 hemB gene Proteins 0.000 claims description 2
• 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 2
• 206010073071 hepatocellular carcinoma Diseases 0.000 claims description 2
• 231100000844 hepatocellular carcinoma Toxicity 0.000 claims description 2
• 201000001421 hyperglycemia Diseases 0.000 claims description 2
• 230000003225 hyperhomocysteinemia Effects 0.000 claims description 2
• 230000003451 hyperinsulinaemic effect Effects 0.000 claims description 2
• 201000008980 hyperinsulinism Diseases 0.000 claims description 2
• 208000034192 hyperlysinemia Diseases 0.000 claims description 2
• 208000008245 hypermethioninemia Diseases 0.000 claims description 2
• 208000023399 hyperprolinemia Diseases 0.000 claims description 2
• 230000001631 hypertensive effect Effects 0.000 claims description 2
• 206010020871 hypertrophic cardiomyopathy Diseases 0.000 claims description 2
• 208000017482 infantile neuronal ceroid lipofuscinosis Diseases 0.000 claims description 2
• 208000036971 interstitial lung disease 2 Diseases 0.000 claims description 2
• 108700036927 isovaleric Acidemia Proteins 0.000 claims description 2
• 208000017476 juvenile neuronal ceroid lipofuscinosis Diseases 0.000 claims description 2
• 210000003734 kidney Anatomy 0.000 claims description 2
• 201000006370 kidney failure Diseases 0.000 claims description 2
• 230000037356 lipid metabolism Effects 0.000 claims description 2
• 231100000835 liver failure Toxicity 0.000 claims description 2
• 208000007903 liver failure Diseases 0.000 claims description 2
• 208000026695 long chain 3-hydroxyacyl-CoA dehydrogenase deficiency Diseases 0.000 claims description 2
• 201000005202 lung cancer Diseases 0.000 claims description 2
• 230000004199 lung function Effects 0.000 claims description 2
• 208000020816 lung neoplasm Diseases 0.000 claims description 2
• 208000024393 maple syrup urine disease Diseases 0.000 claims description 2
• 208000005548 medium chain acyl-CoA dehydrogenase deficiency Diseases 0.000 claims description 2
• 201000003694 methylmalonic acidemia Diseases 0.000 claims description 2
• 201000002273 mucopolysaccharidosis II Diseases 0.000 claims description 2
• 208000005340 mucopolysaccharidosis III Diseases 0.000 claims description 2
• 208000022018 mucopolysaccharidosis type 2 Diseases 0.000 claims description 2
• 208000011045 mucopolysaccharidosis type 3 Diseases 0.000 claims description 2
• 208000010978 mucopolysaccharidosis type 4 Diseases 0.000 claims description 2
• 208000025919 mucopolysaccharidosis type 7 Diseases 0.000 claims description 2
• 201000003645 multiple acyl-CoA dehydrogenase deficiency Diseases 0.000 claims description 2
• 208000010125 myocardial infarction Diseases 0.000 claims description 2
• 208000031225 myocardial ischemia Diseases 0.000 claims description 2
• 201000009240 nasopharyngitis Diseases 0.000 claims description 2
• 201000007633 neuronal ceroid lipofuscinosis 2 Diseases 0.000 claims description 2
• 201000007657 neuronal ceroid lipofuscinosis 5 Diseases 0.000 claims description 2
• 235000020824 obesity Nutrition 0.000 claims description 2
• 201000011278 ornithine carbamoyltransferase deficiency Diseases 0.000 claims description 2
• 208000030613 peripheral artery disease Diseases 0.000 claims description 2
• 208000020930 peroxisome biogenesis disorder 1B Diseases 0.000 claims description 2
• 230000002688 persistence Effects 0.000 claims description 2
• 208000001297 phlebitis Diseases 0.000 claims description 2
• 208000008423 pleurisy Diseases 0.000 claims description 2
• 229920002463 poly(p-dioxanone) polymer Polymers 0.000 claims description 2
• 201000011461 pre-eclampsia Diseases 0.000 claims description 2
• 208000022256 primary systemic amyloidosis Diseases 0.000 claims description 2
• 108020004930 proline dehydrogenase Proteins 0.000 claims description 2
• 201000004012 propionic acidemia Diseases 0.000 claims description 2
• 208000033685 pterin-4 alpha-carbinolamine dehydratase 1 deficiency Diseases 0.000 claims description 2
• 208000002815 pulmonary hypertension Diseases 0.000 claims description 2
• 208000001917 purine nucleoside phosphorylase deficiency Diseases 0.000 claims description 2
• 201000010108 pycnodysostosis Diseases 0.000 claims description 2
• 208000023504 respiratory system disease Diseases 0.000 claims description 2
• 201000000306 sarcoidosis Diseases 0.000 claims description 2
• 206010039722 scoliosis Diseases 0.000 claims description 2
• 208000011985 sialidosis Diseases 0.000 claims description 2
• 201000002859 sleep apnea Diseases 0.000 claims description 2
• 208000026473 slurred speech Diseases 0.000 claims description 2
• 238000013125 spirometry Methods 0.000 claims description 2
• 231100000240 steatosis hepatitis Toxicity 0.000 claims description 2
• CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 claims description 2
• 208000024891 symptom Diseases 0.000 claims description 2
• 230000006794 tachycardia Effects 0.000 claims description 2
• 201000008827 tuberculosis Diseases 0.000 claims description 2
• 201000011296 tyrosinemia Diseases 0.000 claims description 2
• 208000027185 varicose disease Diseases 0.000 claims description 2
• 201000002282 venous insufficiency Diseases 0.000 claims description 2
• 201000010866 very long chain acyl-CoA dehydrogenase deficiency Diseases 0.000 claims description 2
• 208000027121 wild type ATTR amyloidosis Diseases 0.000 claims description 2
• 201000002928 xanthinuria Diseases 0.000 claims description 2
• 102100040896 Growth/differentiation factor 15 Human genes 0.000 claims 8
• 238000010354 CRISPR gene editing Methods 0.000 claims 6
• 101000752037 Homo sapiens Arginase-1 Proteins 0.000 claims 2
• 101000800287 Homo sapiens Tubulointerstitial nephritis antigen-like Proteins 0.000 claims 2
• 102100033469 Tubulointerstitial nephritis antigen-like Human genes 0.000 claims 2
• 102100020925 Adenosylhomocysteinase Human genes 0.000 claims 1
• 102100038910 Alpha-enolase Human genes 0.000 claims 1
• 102100035388 Beta-enolase Human genes 0.000 claims 1
• 102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 claims 1
• 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 claims 1
• 102100035041 Dimethylaniline monooxygenase [N-oxide-forming] 3 Human genes 0.000 claims 1
• 201000011240 Frontotemporal dementia Diseases 0.000 claims 1
• 102100037181 Fructose-1,6-bisphosphatase 1 Human genes 0.000 claims 1
• 102100028652 Gamma-enolase Human genes 0.000 claims 1
• 102100040677 Glycine N-methyltransferase Human genes 0.000 claims 1
• 101000716952 Homo sapiens Adenosylhomocysteinase Proteins 0.000 claims 1
• 101000882335 Homo sapiens Alpha-enolase Proteins 0.000 claims 1
• 101000877537 Homo sapiens Beta-enolase Proteins 0.000 claims 1
• 101001045440 Homo sapiens Beta-hexosaminidase subunit alpha Proteins 0.000 claims 1
• 101000855412 Homo sapiens Carbamoyl-phosphate synthase [ammonia], mitochondrial Proteins 0.000 claims 1
• 101000866302 Homo sapiens Excitatory amino acid transporter 3 Proteins 0.000 claims 1
• 101001028852 Homo sapiens Fructose-1,6-bisphosphatase 1 Proteins 0.000 claims 1
• 101001058231 Homo sapiens Gamma-enolase Proteins 0.000 claims 1
• 101001039280 Homo sapiens Glycine N-methyltransferase Proteins 0.000 claims 1
• 101000941071 Homo sapiens Lysosomal cobalamin transport escort protein LMBD1 Proteins 0.000 claims 1
• 101000983292 Homo sapiens N-fatty-acyl-amino acid synthase/hydrolase PM20D1 Proteins 0.000 claims 1
• 101001021103 Homo sapiens Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial Proteins 0.000 claims 1
• 101001055594 Homo sapiens S-adenosylmethionine synthase isoform type-1 Proteins 0.000 claims 1
• 101000861263 Homo sapiens Steroid 21-hydroxylase Proteins 0.000 claims 1
• 101000838086 Homo sapiens Transaldolase Proteins 0.000 claims 1
• 208000009625 Lesch-Nyhan syndrome Diseases 0.000 claims 1
• 102100031335 Lysosomal cobalamin transport escort protein LMBD1 Human genes 0.000 claims 1
• 102100026873 N-fatty-acyl-amino acid synthase/hydrolase PM20D1 Human genes 0.000 claims 1
• 102000004473 OX40 Ligand Human genes 0.000 claims 1
• 108010042215 OX40 Ligand Proteins 0.000 claims 1
• 102100036201 Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial Human genes 0.000 claims 1
• 208000000609 Pick Disease of the Brain Diseases 0.000 claims 1
• 208000024571 Pick disease Diseases 0.000 claims 1
• 102100026115 S-adenosylmethionine synthase isoform type-1 Human genes 0.000 claims 1
• 102000012979 SLC1A1 Human genes 0.000 claims 1
• 108091006418 SLC25A13 Proteins 0.000 claims 1
• 208000035317 Total hypoxanthine-guanine phosphoribosyl transferase deficiency Diseases 0.000 claims 1
• 102100028601 Transaldolase Human genes 0.000 claims 1
• 208000020832 chronic kidney disease Diseases 0.000 claims 1
• 108010057167 dimethylaniline monooxygenase (N-oxide forming) Proteins 0.000 claims 1
• VLMZMRDOMOGGFA-WDBKCZKBSA-N festuclavine Chemical compound C1=CC([C@H]2C[C@H](CN(C)[C@@H]2C2)C)=C3C2=CNC3=C1 VLMZMRDOMOGGFA-WDBKCZKBSA-N 0.000 claims 1
• 230000008672 reprogramming Effects 0.000 abstract description 18
• 239000002537 cosmetic Substances 0.000 abstract description 16
• 210000000056 organ Anatomy 0.000 abstract description 7
• 230000001939 inductive effect Effects 0.000 abstract description 4
• 229920002477 rna polymer Polymers 0.000 description 254
• 210000005175 epidermal keratinocyte Anatomy 0.000 description 28
• 230000014509 gene expression Effects 0.000 description 25
• 238000001890 transfection Methods 0.000 description 22
• 229960002756 azacitidine Drugs 0.000 description 19
• 238000002474 experimental method Methods 0.000 description 19
• 230000001225 therapeutic effect Effects 0.000 description 19
• 108020004414 DNA Proteins 0.000 description 17
• 238000006243 chemical reaction Methods 0.000 description 17
• MPDKOGQMQLSNOF-GBNDHIKLSA-N 2-amino-5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-pyrimidin-6-one Chemical compound O=C1NC(N)=NC=C1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 MPDKOGQMQLSNOF-GBNDHIKLSA-N 0.000 description 14
• 229940096913 pseudoisocytidine Drugs 0.000 description 14
• 238000012384 transportation and delivery Methods 0.000 description 14
• LZCNWAXLJWBRJE-ZOQUXTDFSA-N N4-Methylcytidine Chemical compound O=C1N=C(NC)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 LZCNWAXLJWBRJE-ZOQUXTDFSA-N 0.000 description 12
• 125000003275 alpha amino acid group Chemical group 0.000 description 12
• 239000000243 solution Substances 0.000 description 12
• 210000001519 tissue Anatomy 0.000 description 12
• 239000003981 vehicle Substances 0.000 description 12
• 230000001988 toxicity Effects 0.000 description 11
• 231100000419 toxicity Toxicity 0.000 description 11
• 238000002965 ELISA Methods 0.000 description 10
• 102000000597 Growth Differentiation Factor 15 Human genes 0.000 description 10
• 235000021120 animal protein Nutrition 0.000 description 10
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
• 210000002950 fibroblast Anatomy 0.000 description 9
• 235000002639 sodium chloride Nutrition 0.000 description 9
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 8
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 8
• 229940079593 drug Drugs 0.000 description 8
• 239000005090 green fluorescent protein Substances 0.000 description 8
• 239000004417 polycarbonate Substances 0.000 description 8
• 229920001223 polyethylene glycol Polymers 0.000 description 8
• 239000000047 product Substances 0.000 description 8
• 230000002459 sustained effect Effects 0.000 description 8
• 239000001226 triphosphate Substances 0.000 description 8
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 7
• GJTBSTBJLVYKAU-XVFCMESISA-N 2-thiouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=S)NC(=O)C=C1 GJTBSTBJLVYKAU-XVFCMESISA-N 0.000 description 7
• LZWSGWMPCIAGIJ-UAKXSSHOSA-N 4,5-diamino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one Chemical compound O=C1N=C(N)C(N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 LZWSGWMPCIAGIJ-UAKXSSHOSA-N 0.000 description 7
• ZLOIGESWDJYCTF-UHFFFAOYSA-N 4-Thiouridine Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=S)C=C1 ZLOIGESWDJYCTF-UHFFFAOYSA-N 0.000 description 7
• ZLOIGESWDJYCTF-XVFCMESISA-N 4-thiouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=S)C=C1 ZLOIGESWDJYCTF-XVFCMESISA-N 0.000 description 7
• TUZRSOLHFXTHNA-ZEQWWUPGSA-N 5-amino-5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione Chemical compound NC1([C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)C=NC(=O)NC1=O TUZRSOLHFXTHNA-ZEQWWUPGSA-N 0.000 description 7
• 101150056204 COL7A1 gene Proteins 0.000 description 7
• 102000053602 DNA Human genes 0.000 description 7
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 7
• 101100496573 Homo sapiens COL7A1 gene Proteins 0.000 description 7
• 108091028043 Nucleic acid sequence Proteins 0.000 description 7
• 239000002202 Polyethylene glycol Substances 0.000 description 7
• 238000012937 correction Methods 0.000 description 7
• 230000002500 effect on skin Effects 0.000 description 7
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 7
• 239000001963 growth medium Substances 0.000 description 7
• 108020004999 messenger RNA Proteins 0.000 description 7
• 239000012096 transfection reagent Substances 0.000 description 7
• 238000013293 zucker diabetic fatty rat Methods 0.000 description 7
• BNAWMJKJLNJZFU-GBNDHIKLSA-N 5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-sulfanylidene-1h-pyrimidin-2-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CNC(=O)NC1=S BNAWMJKJLNJZFU-GBNDHIKLSA-N 0.000 description 6
• YBTWWWIJBCCYNR-UAKXSSHOSA-N 5-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 YBTWWWIJBCCYNR-UAKXSSHOSA-N 0.000 description 6
• 238000003556 assay Methods 0.000 description 6
• 238000010195 expression analysis Methods 0.000 description 6
• 239000012634 fragment Substances 0.000 description 6
• 239000002609 medium Substances 0.000 description 6
• 239000002105 nanoparticle Substances 0.000 description 6
• 150000003839 salts Chemical class 0.000 description 6
• RHFUOMFWUGWKKO-XVFCMESISA-N 2-thiocytidine Chemical compound S=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 RHFUOMFWUGWKKO-XVFCMESISA-N 0.000 description 5
• 230000033616 DNA repair Effects 0.000 description 5
• 102000003812 Interleukin-15 Human genes 0.000 description 5
• 108090000172 Interleukin-15 Proteins 0.000 description 5
• 108090001005 Interleukin-6 Proteins 0.000 description 5
• NIDVTARKFBZMOT-PEBGCTIMSA-N N(4)-acetylcytidine Chemical compound O=C1N=C(NC(=O)C)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NIDVTARKFBZMOT-PEBGCTIMSA-N 0.000 description 5
• 108020004682 Single-Stranded DNA Proteins 0.000 description 5
• 125000004429 atom Chemical group 0.000 description 5
• 239000003795 chemical substances by application Substances 0.000 description 5
• 230000002068 genetic effect Effects 0.000 description 5
• 230000001404 mediated effect Effects 0.000 description 5
• 239000001294 propane Substances 0.000 description 5
• RHFUOMFWUGWKKO-UHFFFAOYSA-N s2C Natural products S=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 RHFUOMFWUGWKKO-UHFFFAOYSA-N 0.000 description 5
• 239000000523 sample Substances 0.000 description 5
• KYEKLQMDNZPEFU-KVTDHHQDSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazine-2,4-dione Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)N=C1 KYEKLQMDNZPEFU-KVTDHHQDSA-N 0.000 description 4
• UVBYMVOUBXYSFV-XUTVFYLZSA-N 1-methylpseudouridine Chemical compound O=C1NC(=O)N(C)C=C1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 UVBYMVOUBXYSFV-XUTVFYLZSA-N 0.000 description 4
• OTDJAMXESTUWLO-UUOKFMHZSA-N 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-3H-purine-6-thione Chemical compound C12=NC(N)=NC(S)=C2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OTDJAMXESTUWLO-UUOKFMHZSA-N 0.000 description 4
• NMUSYJAQQFHJEW-UHFFFAOYSA-N 5-Azacytidine Natural products O=C1N=C(N)N=CN1C1C(O)C(O)C(CO)O1 NMUSYJAQQFHJEW-UHFFFAOYSA-N 0.000 description 4
• DDHOXEOVAJVODV-GBNDHIKLSA-N 5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CNC(=S)NC1=O DDHOXEOVAJVODV-GBNDHIKLSA-N 0.000 description 4
• NMUSYJAQQFHJEW-KVTDHHQDSA-N 5-azacytidine Chemical compound O=C1N=C(N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NMUSYJAQQFHJEW-KVTDHHQDSA-N 0.000 description 4
• CBNRZZNSRJQZNT-IOSLPCCCSA-O 6-thio-7-deaza-guanosine Chemical compound CC1=C[NH+]([C@@H]([C@@H]2O)O[C@H](CO)[C@H]2O)C(NC(N)=N2)=C1C2=S CBNRZZNSRJQZNT-IOSLPCCCSA-O 0.000 description 4
• HDZZVAMISRMYHH-UHFFFAOYSA-N 9beta-Ribofuranosyl-7-deazaadenin Natural products C1=CC=2C(N)=NC=NC=2N1C1OC(CO)C(O)C1O HDZZVAMISRMYHH-UHFFFAOYSA-N 0.000 description 4
• 108010019673 Darbepoetin alfa Proteins 0.000 description 4
• 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 102000004889 Interleukin-6 Human genes 0.000 description 4
• VQAYFKKCNSOZKM-IOSLPCCCSA-N N(6)-methyladenosine Chemical compound C1=NC=2C(NC)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O VQAYFKKCNSOZKM-IOSLPCCCSA-N 0.000 description 4
• VQAYFKKCNSOZKM-UHFFFAOYSA-N NSC 29409 Natural products C1=NC=2C(NC)=NC=NC=2N1C1OC(CO)C(O)C1O VQAYFKKCNSOZKM-UHFFFAOYSA-N 0.000 description 4
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
• 239000000427 antigen Substances 0.000 description 4
• 108091007433 antigens Proteins 0.000 description 4
• 102000036639 antigens Human genes 0.000 description 4
• 230000009286 beneficial effect Effects 0.000 description 4
• 229910052799 carbon Inorganic materials 0.000 description 4
• 235000012000 cholesterol Nutrition 0.000 description 4
• 238000003776 cleavage reaction Methods 0.000 description 4
• DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
• 229960005029 darbepoetin alfa Drugs 0.000 description 4
• MWRBNPKJOOWZPW-CLFAGFIQSA-N dioleoyl phosphatidylethanolamine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(=O)OCCN)OC(=O)CCCCCCC\C=C/CCCCCCCC MWRBNPKJOOWZPW-CLFAGFIQSA-N 0.000 description 4
• 238000012632 fluorescent imaging Methods 0.000 description 4
• 210000000245 forearm Anatomy 0.000 description 4
• 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 4
• 238000005534 hematocrit Methods 0.000 description 4
• 230000008105 immune reaction Effects 0.000 description 4
• 238000010348 incorporation Methods 0.000 description 4
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
• 238000010253 intravenous injection Methods 0.000 description 4
• 238000011068 loading method Methods 0.000 description 4
• 102000040430 polynucleotide Human genes 0.000 description 4
• 108091033319 polynucleotide Proteins 0.000 description 4
• 239000002157 polynucleotide Substances 0.000 description 4
• 230000007017 scission Effects 0.000 description 4
• 210000003491 skin Anatomy 0.000 description 4
• 230000008685 targeting Effects 0.000 description 4
• HDZZVAMISRMYHH-KCGFPETGSA-N tubercidin Chemical compound C1=CC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O HDZZVAMISRMYHH-KCGFPETGSA-N 0.000 description 4
• 239000013603 viral vector Substances 0.000 description 4
• 230000003612 virological effect Effects 0.000 description 4
• 108010083359 Antigen Receptors Proteins 0.000 description 3
• 102000006306 Antigen Receptors Human genes 0.000 description 3
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
• 108091006146 Channels Proteins 0.000 description 3
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
• 102000004190 Enzymes Human genes 0.000 description 3
• 108090000790 Enzymes Proteins 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 3
• 241000700159 Rattus Species 0.000 description 3
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
• 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 3
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
• 239000006143 cell culture medium Substances 0.000 description 3
• 230000030833 cell death Effects 0.000 description 3
• 230000008859 change Effects 0.000 description 3
• MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
• 239000002552 dosage form Substances 0.000 description 3
• 229940088598 enzyme Drugs 0.000 description 3
• 239000012091 fetal bovine serum Substances 0.000 description 3
• 150000004679 hydroxides Chemical class 0.000 description 3
• WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
• 230000003993 interaction Effects 0.000 description 3
• 239000007925 intracardiac injection Substances 0.000 description 3
• 238000007913 intrathecal administration Methods 0.000 description 3
• 230000002601 intratumoral effect Effects 0.000 description 3
• 230000000670 limiting effect Effects 0.000 description 3
• 239000007788 liquid Substances 0.000 description 3
• 239000003550 marker Substances 0.000 description 3
• 239000000463 material Substances 0.000 description 3
• 238000007069 methylation reaction Methods 0.000 description 3
• 210000001331 nose Anatomy 0.000 description 3
• 125000004430 oxygen atom Chemical group O* 0.000 description 3
• 230000037361 pathway Effects 0.000 description 3
• 239000000825 pharmaceutical preparation Substances 0.000 description 3
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
• 239000011780 sodium chloride Substances 0.000 description 3
• 238000002560 therapeutic procedure Methods 0.000 description 3
• 238000011269 treatment regimen Methods 0.000 description 3
• QROZCFCNYCVEDO-KQYNXXCUSA-N (2r,3r,4s,5r)-2-[6-(hydroxyamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(NO)=C2N=C1 QROZCFCNYCVEDO-KQYNXXCUSA-N 0.000 description 2
• UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 2
• UVBYMVOUBXYSFV-UHFFFAOYSA-N 1-methylpseudouridine Natural products O=C1NC(=O)N(C)C=C1C1C(O)C(O)C(CO)O1 UVBYMVOUBXYSFV-UHFFFAOYSA-N 0.000 description 2
• VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
• LDGWQMRUWMSZIU-LQDDAWAPSA-M 2,3-bis[(z)-octadec-9-enoxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCCOCC(C[N+](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC LDGWQMRUWMSZIU-LQDDAWAPSA-M 0.000 description 2
• YDGHCPCSMRXRSN-UAKXSSHOSA-N 5-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(hydroxyamino)pyrimidin-2-one Chemical compound O=C1N=C(NO)C(N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 YDGHCPCSMRXRSN-UAKXSSHOSA-N 0.000 description 2
• QOVIBFFZCVPCEI-UMMCILCDSA-N 5-amino-3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6H-triazolo[4,5-d]pyrimidin-7-one Chemical compound N1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O QOVIBFFZCVPCEI-UMMCILCDSA-N 0.000 description 2
• MJJUWOIBPREHRU-MWKIOEHESA-N 7-Deaza-8-azaguanosine Chemical compound NC=1NC(C2=C(N=1)N(N=C2)[C@H]1[C@H](O)[C@H](O)[C@H](O1)CO)=O MJJUWOIBPREHRU-MWKIOEHESA-N 0.000 description 2
• 229930024421 Adenine Natural products 0.000 description 2
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
• 102100026882 Alpha-synuclein Human genes 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
• 102000008186 Collagen Human genes 0.000 description 2
• 108010035532 Collagen Proteins 0.000 description 2
• 102100024335 Collagen alpha-1(VII) chain Human genes 0.000 description 2
• 208000035473 Communicable disease Diseases 0.000 description 2
• MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 2
• UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 2
• PCDQPRRSZKQHHS-UHFFFAOYSA-N Cytidine 5'-triphosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 PCDQPRRSZKQHHS-UHFFFAOYSA-N 0.000 description 2
• 102000004127 Cytokines Human genes 0.000 description 2
• 108090000695 Cytokines Proteins 0.000 description 2
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
• 208000010975 Dystrophic epidermolysis bullosa Diseases 0.000 description 2
• 102100033167 Elastin Human genes 0.000 description 2
• 108010014258 Elastin Proteins 0.000 description 2
• QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
• 108090000376 Fibroblast growth factor 21 Proteins 0.000 description 2
• 102000003973 Fibroblast growth factor 21 Human genes 0.000 description 2
• 102100037362 Fibronectin Human genes 0.000 description 2
• 108010067306 Fibronectins Proteins 0.000 description 2
• 108010010803 Gelatin Proteins 0.000 description 2
• 101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 description 2
• 101000909498 Homo sapiens Collagen alpha-1(VII) chain Proteins 0.000 description 2
• 101000899111 Homo sapiens Hemoglobin subunit beta Proteins 0.000 description 2
• 101001054334 Homo sapiens Interferon beta Proteins 0.000 description 2
• 101000883798 Homo sapiens Probable ATP-dependent RNA helicase DDX53 Proteins 0.000 description 2
• 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 description 2
• 101000655352 Homo sapiens Telomerase reverse transcriptase Proteins 0.000 description 2
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
• 108090001061 Insulin Proteins 0.000 description 2
• 102000004877 Insulin Human genes 0.000 description 2
• 108010050904 Interferons Proteins 0.000 description 2
• 102000003814 Interleukin-10 Human genes 0.000 description 2
• 108090000174 Interleukin-10 Proteins 0.000 description 2
• 102000003816 Interleukin-13 Human genes 0.000 description 2
• 108090000176 Interleukin-13 Proteins 0.000 description 2
• 102000000588 Interleukin-2 Human genes 0.000 description 2
• 108010002350 Interleukin-2 Proteins 0.000 description 2
• 102100026236 Interleukin-8 Human genes 0.000 description 2
• 102000011782 Keratins Human genes 0.000 description 2
• 108010076876 Keratins Proteins 0.000 description 2
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
• 108700011259 MicroRNAs Proteins 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• 108090000445 Parathyroid hormone Proteins 0.000 description 2
• 102000003982 Parathyroid hormone Human genes 0.000 description 2
• 208000012641 Pigmentation disease Diseases 0.000 description 2
• 102100038236 Probable ATP-dependent RNA helicase DDX53 Human genes 0.000 description 2
• RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
• ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
• 208000035977 Rare disease Diseases 0.000 description 2
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
• 229920002472 Starch Polymers 0.000 description 2
• 101710137500 T7 RNA polymerase Proteins 0.000 description 2
• 108010073062 Transcription Activator-Like Effectors Proteins 0.000 description 2
• GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
• DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 2
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
• 102100035140 Vitronectin Human genes 0.000 description 2
• 108010031318 Vitronectin Proteins 0.000 description 2
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
• NYDLOCKCVISJKK-WRBBJXAJSA-N [3-(dimethylamino)-2-[(z)-octadec-9-enoyl]oxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(CN(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC NYDLOCKCVISJKK-WRBBJXAJSA-N 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 229960000643 adenine Drugs 0.000 description 2
• 229960005305 adenosine Drugs 0.000 description 2
• 238000009098 adjuvant therapy Methods 0.000 description 2
• 210000002159 anterior chamber Anatomy 0.000 description 2
• 230000000844 anti-bacterial effect Effects 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• 239000003833 bile salt Substances 0.000 description 2
• 230000027455 binding Effects 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 210000003161 choroid Anatomy 0.000 description 2
• 210000004240 ciliary body Anatomy 0.000 description 2
• 229940001468 citrate Drugs 0.000 description 2
• 229920001436 collagen Polymers 0.000 description 2
• 239000003086 colorant Substances 0.000 description 2
• 210000000795 conjunctiva Anatomy 0.000 description 2
• 210000004087 cornea Anatomy 0.000 description 2
• 229940109239 creatinine Drugs 0.000 description 2
• 210000000695 crystalline len Anatomy 0.000 description 2
• PCDQPRRSZKQHHS-ZAKLUEHWSA-N cytidine-5'-triphosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO[P@](O)(=O)O[P@@](O)(=O)OP(O)(O)=O)O1 PCDQPRRSZKQHHS-ZAKLUEHWSA-N 0.000 description 2
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
• 230000002354 daily effect Effects 0.000 description 2
• GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
• 230000004069 differentiation Effects 0.000 description 2
• 230000029087 digestion Effects 0.000 description 2
• 238000010790 dilution Methods 0.000 description 2
• 239000012895 dilution Substances 0.000 description 2
• POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
• 210000005069 ears Anatomy 0.000 description 2
• 230000005014 ectopic expression Effects 0.000 description 2
• 229920002549 elastin Polymers 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 208000004298 epidermolysis bullosa dystrophica Diseases 0.000 description 2
• 230000010437 erythropoiesis Effects 0.000 description 2
• CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 2
• 210000001508 eye Anatomy 0.000 description 2
• 210000000744 eyelid Anatomy 0.000 description 2
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
• 229940014144 folate Drugs 0.000 description 2
• OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
• 235000019152 folic acid Nutrition 0.000 description 2
• 239000011724 folic acid Substances 0.000 description 2
• 210000002683 foot Anatomy 0.000 description 2
• 102000037865 fusion proteins Human genes 0.000 description 2
• 108020001507 fusion proteins Proteins 0.000 description 2
• 239000008273 gelatin Substances 0.000 description 2
• 229920000159 gelatin Polymers 0.000 description 2
• 235000019322 gelatine Nutrition 0.000 description 2
• 235000011852 gelatine desserts Nutrition 0.000 description 2
• 229940029575 guanosine Drugs 0.000 description 2
• 210000004209 hair Anatomy 0.000 description 2
• 230000035876 healing Effects 0.000 description 2
• 238000004128 high performance liquid chromatography Methods 0.000 description 2
• 102000046107 human BMP7 Human genes 0.000 description 2
• 239000008350 hydrogenated phosphatidyl choline Substances 0.000 description 2
• 230000005847 immunogenicity Effects 0.000 description 2
• 239000003018 immunosuppressive agent Substances 0.000 description 2
• 230000001976 improved effect Effects 0.000 description 2
• 208000015181 infectious disease Diseases 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• 230000005764 inhibitory process Effects 0.000 description 2
• 210000005007 innate immune system Anatomy 0.000 description 2
• 229940125396 insulin Drugs 0.000 description 2
• 210000000554 iris Anatomy 0.000 description 2
• 210000001232 limbus corneae Anatomy 0.000 description 2
• 231100000053 low toxicity Toxicity 0.000 description 2
• 238000012423 maintenance Methods 0.000 description 2
• 239000011159 matrix material Substances 0.000 description 2
• QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
• 239000000693 micelle Substances 0.000 description 2
• 239000002679 microRNA Substances 0.000 description 2
• 210000000282 nail Anatomy 0.000 description 2
• 239000013642 negative control Substances 0.000 description 2
• 239000002777 nucleoside Substances 0.000 description 2
• 150000003833 nucleoside derivatives Chemical class 0.000 description 2
• 210000001328 optic nerve Anatomy 0.000 description 2
• 239000000199 parathyroid hormone Substances 0.000 description 2
• 229960001319 parathyroid hormone Drugs 0.000 description 2
• 238000007911 parenteral administration Methods 0.000 description 2
• 229940124531 pharmaceutical excipient Drugs 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
• 239000010452 phosphate Substances 0.000 description 2
• 150000008105 phosphatidylcholines Chemical class 0.000 description 2
• 239000013612 plasmid Substances 0.000 description 2
• WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
• 230000008439 repair process Effects 0.000 description 2
• 230000010076 replication Effects 0.000 description 2
• 238000011160 research Methods 0.000 description 2
• 210000001525 retina Anatomy 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 2
• 210000003786 sclera Anatomy 0.000 description 2
• 210000001082 somatic cell Anatomy 0.000 description 2
• 229940063675 spermine Drugs 0.000 description 2
• PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
• 235000019698 starch Nutrition 0.000 description 2
• 239000008107 starch Substances 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 239000000126 substance Substances 0.000 description 2
• 239000004094 surface-active agent Substances 0.000 description 2
• 239000000454 talc Substances 0.000 description 2
• 229910052623 talc Inorganic materials 0.000 description 2
• 229920003046 tetrablock copolymer Polymers 0.000 description 2
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
• 230000014616 translation Effects 0.000 description 2
• 238000013519 translation Methods 0.000 description 2
• 150000003626 triacylglycerols Chemical class 0.000 description 2
• 235000011178 triphosphate Nutrition 0.000 description 2
• UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 2
• 230000003827 upregulation Effects 0.000 description 2
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
• 229910052725 zinc Inorganic materials 0.000 description 2
• 239000011701 zinc Substances 0.000 description 2
• IMEBVVPYOVUBKA-UUOKFMHZSA-N (2R,3R,4S,5R)-2-[7-(hydroxyamino)triazolo[4,5-d]pyrimidin-3-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1nnc2c(NO)ncnc12 IMEBVVPYOVUBKA-UUOKFMHZSA-N 0.000 description 1
• AXQXEESRUDHXPL-CYTDFRIRSA-N (2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-(5-methoxy-2,6-dioxopyrimidin-5-yl)oxolane-2-carboxylic acid Chemical group COC1(C=NC(=O)NC1=O)[C@@]1(O[C@H](CO)[C@@H](O)[C@H]1O)C(O)=O AXQXEESRUDHXPL-CYTDFRIRSA-N 0.000 description 1
• DGKZTAGCCXJUAT-KQYNXXCUSA-N (2r,3r,4s,5r)-2-(6-hydrazinylpurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C1=NC=2C(NN)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O DGKZTAGCCXJUAT-KQYNXXCUSA-N 0.000 description 1
• KLNYEFMNJOUCTO-UUOKFMHZSA-N (2r,3r,4s,5r)-2-(7-hydrazinyltriazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound N1=NC=2C(NN)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O KLNYEFMNJOUCTO-UUOKFMHZSA-N 0.000 description 1
• IFCGNCLEKGDBDJ-KQYNXXCUSA-N (2r,3s,4r,5r)-2-(hydroxymethyl)-5-[7-(methylamino)triazolo[4,5-d]pyrimidin-3-yl]oxolane-3,4-diol Chemical compound N1=NC=2C(NC)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O IFCGNCLEKGDBDJ-KQYNXXCUSA-N 0.000 description 1
• RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 description 1
• CCEITODEOHVTFL-DBRKOABJSA-N (4Z)-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydrazinylidene-5-methyl-1,3,5-triazinan-2-one Chemical compound CN1CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N=C1NN CCEITODEOHVTFL-DBRKOABJSA-N 0.000 description 1
• GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
• LVNGJLRDBYCPGB-LDLOPFEMSA-N (R)-1,2-distearoylphosphatidylethanolamine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[NH3+])OC(=O)CCCCCCCCCCCCCCCCC LVNGJLRDBYCPGB-LDLOPFEMSA-N 0.000 description 1
• AFENDNXGAFYKQO-VKHMYHEASA-N (S)-2-hydroxybutyric acid Chemical compound CC[C@H](O)C(O)=O AFENDNXGAFYKQO-VKHMYHEASA-N 0.000 description 1
• UWYVPFMHMJIBHE-OWOJBTEDSA-N (e)-2-hydroxybut-2-enedioic acid Chemical compound OC(=O)\C=C(\O)C(O)=O UWYVPFMHMJIBHE-OWOJBTEDSA-N 0.000 description 1
• NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
• ABGLXZLYLBSFDZ-KVTDHHQDSA-N 1,6-diamino-3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2h-1,3,5-triazin-4-one Chemical compound O=C1N=C(N)N(N)CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 ABGLXZLYLBSFDZ-KVTDHHQDSA-N 0.000 description 1
• ARYVNLRUDOYCGR-KVTDHHQDSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(hydroxyamino)-1,3,5-triazin-2-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N=C(NO)N=C1 ARYVNLRUDOYCGR-KVTDHHQDSA-N 0.000 description 1
• FIAQJMSWEWAREU-JXOAFFINSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(hydroxyamino)-5-methylpyrimidin-2-one Chemical compound O=C1N=C(NO)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 FIAQJMSWEWAREU-JXOAFFINSA-N 0.000 description 1
• WVMPZTYBROSQRJ-DBRKOABJSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(methylamino)-1,3,5-triazin-2-one Chemical compound O=C1N=C(NC)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 WVMPZTYBROSQRJ-DBRKOABJSA-N 0.000 description 1
• OQDGQWRCJQEJRX-KVTDHHQDSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydrazinyl-1,3,5-triazin-2-one Chemical compound O=C1N=C(NN)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 OQDGQWRCJQEJRX-KVTDHHQDSA-N 0.000 description 1
• MHOFECSHUOJTRF-UAKXSSHOSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydrazinyl-5-hydroxypyrimidin-2-one Chemical compound C1=C(O)C(NN)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 MHOFECSHUOJTRF-UAKXSSHOSA-N 0.000 description 1
• YUNJBQDCTLSQCZ-JXOAFFINSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydrazinyl-5-methylpyrimidin-2-one Chemical compound O=C1N=C(NN)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 YUNJBQDCTLSQCZ-JXOAFFINSA-N 0.000 description 1
• RSSRMDMJEZIUJX-XVFCMESISA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydrazinylpyrimidin-2-one Chemical compound O=C1N=C(NN)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 RSSRMDMJEZIUJX-XVFCMESISA-N 0.000 description 1
• RNKDWPJBJIFTKV-KVTDHHQDSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxy-1,3,5-triazinane-2,4-dione Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)N(O)C1 RNKDWPJBJIFTKV-KVTDHHQDSA-N 0.000 description 1
• UXCALUXXUFSTBY-UAKXSSHOSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxy-4-(hydroxyamino)pyrimidin-2-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N=C(NO)C(O)=C1 UXCALUXXUFSTBY-UAKXSSHOSA-N 0.000 description 1
• LKBQDNUCHULBBA-JXOAFFINSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxy-4-(methylamino)pyrimidin-2-one Chemical compound C1=C(O)C(NC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 LKBQDNUCHULBBA-JXOAFFINSA-N 0.000 description 1
• FQLVAQCZHLHEIP-DBRKOABJSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,3,5-triazinane-2,4-dione Chemical compound O=C1NC(=O)N(C)CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 FQLVAQCZHLHEIP-DBRKOABJSA-N 0.000 description 1
• QJFQWYBWIIJENY-FDDDBJFASA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-4-(methylamino)pyrimidin-2-one Chemical compound C1=C(C)C(NC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 QJFQWYBWIIJENY-FDDDBJFASA-N 0.000 description 1
• WOWKPCXEBJGZMT-KVTDHHQDSA-N 1-amino-3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(hydroxyamino)-2h-1,3,5-triazin-4-one Chemical compound O=C1N=C(NO)N(N)CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 WOWKPCXEBJGZMT-KVTDHHQDSA-N 0.000 description 1
• CNDJSOTUEUHZDN-KVTDHHQDSA-N 1-amino-3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-hydrazinyl-2h-1,3,5-triazin-4-one Chemical compound C1N(N)C(NN)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 CNDJSOTUEUHZDN-KVTDHHQDSA-N 0.000 description 1
• YIBJSENXVGMWRM-KVTDHHQDSA-N 1-amino-5-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazinane-2,4-dione Chemical compound O=C1NC(=O)N(N)CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 YIBJSENXVGMWRM-KVTDHHQDSA-N 0.000 description 1
• 102100027769 2'-5'-oligoadenylate synthase 1 Human genes 0.000 description 1
• 102100027621 2'-5'-oligoadenylate synthase 2 Human genes 0.000 description 1
• 102100035389 2'-5'-oligoadenylate synthase 3 Human genes 0.000 description 1
• 102100035473 2'-5'-oligoadenylate synthase-like protein Human genes 0.000 description 1
• KSXTUUUQYQYKCR-LQDDAWAPSA-M 2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC KSXTUUUQYQYKCR-LQDDAWAPSA-M 0.000 description 1
• NTTZBBIBMSBLNK-UHFFFAOYSA-M 2,3-di(octadecanoyloxy)propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC NTTZBBIBMSBLNK-UHFFFAOYSA-M 0.000 description 1
• HCSBTDBGTNZOAB-UHFFFAOYSA-N 2,3-dinitrobenzoic acid Chemical compound OC(=O)C1=CC=CC([N+]([O-])=O)=C1[N+]([O-])=O HCSBTDBGTNZOAB-UHFFFAOYSA-N 0.000 description 1
• WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 1
• YMZPQKXPKZZSFV-CPWYAANMSA-N 2-[3-[(1r)-1-[(2s)-1-[(2s)-2-[(1r)-cyclohex-2-en-1-yl]-2-(3,4,5-trimethoxyphenyl)acetyl]piperidine-2-carbonyl]oxy-3-(3,4-dimethoxyphenyl)propyl]phenoxy]acetic acid Chemical compound C1=C(OC)C(OC)=CC=C1CC[C@H](C=1C=C(OCC(O)=O)C=CC=1)OC(=O)[C@H]1N(C(=O)[C@@H]([C@H]2C=CCCC2)C=2C=C(OC)C(OC)=C(OC)C=2)CCCC1 YMZPQKXPKZZSFV-CPWYAANMSA-N 0.000 description 1
• GXAFMKJFWWBYNW-OWHBQTKESA-N 2-[3-[(1r)-1-[(2s)-1-[(2s)-3-cyclopropyl-2-(3,4,5-trimethoxyphenyl)propanoyl]piperidine-2-carbonyl]oxy-3-(3,4-dimethoxyphenyl)propyl]phenoxy]acetic acid Chemical compound C1=C(OC)C(OC)=CC=C1CC[C@H](C=1C=C(OCC(O)=O)C=CC=1)OC(=O)[C@H]1N(C(=O)[C@@H](CC2CC2)C=2C=C(OC)C(OC)=C(OC)C=2)CCCC1 GXAFMKJFWWBYNW-OWHBQTKESA-N 0.000 description 1
• GTVAUHXUMYENSK-RWSKJCERSA-N 2-[3-[(1r)-3-(3,4-dimethoxyphenyl)-1-[(2s)-1-[(2s)-2-(3,4,5-trimethoxyphenyl)pent-4-enoyl]piperidine-2-carbonyl]oxypropyl]phenoxy]acetic acid Chemical compound C1=C(OC)C(OC)=CC=C1CC[C@H](C=1C=C(OCC(O)=O)C=CC=1)OC(=O)[C@H]1N(C(=O)[C@@H](CC=C)C=2C=C(OC)C(OC)=C(OC)C=2)CCCC1 GTVAUHXUMYENSK-RWSKJCERSA-N 0.000 description 1
• IVHKZCSZELZKSJ-UHFFFAOYSA-N 2-hydroxyethyl sulfonate Chemical compound OCCOS(=O)=O IVHKZCSZELZKSJ-UHFFFAOYSA-N 0.000 description 1
• HMGCGUWFPZVPEK-UHFFFAOYSA-N 2-naphthalen-2-ylbenzoic acid Chemical compound OC(=O)C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=C1 HMGCGUWFPZVPEK-UHFFFAOYSA-N 0.000 description 1
• DXEJZRDJXRVUPN-XUTVFYLZSA-N 3-Methylpseudouridine Chemical compound O=C1N(C)C(=O)NC=C1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 DXEJZRDJXRVUPN-XUTVFYLZSA-N 0.000 description 1
• IYPBDMKBQJGCLT-KVTDHHQDSA-N 3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1-hydroxy-6-(hydroxyamino)-2h-1,3,5-triazin-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N=C(NO)N(O)C1 IYPBDMKBQJGCLT-KVTDHHQDSA-N 0.000 description 1
• HHAAQEZYQXNVDN-DBRKOABJSA-N 3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1-hydroxy-6-(methylamino)-2h-1,3,5-triazin-4-one Chemical compound C1N(O)C(NC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 HHAAQEZYQXNVDN-DBRKOABJSA-N 0.000 description 1
• LWOXGYIDLHBWQL-WCTZXXKLSA-N 3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1-methyl-6-(methylamino)-2h-1,3,5-triazin-4-one Chemical compound C1N(C)C(NC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 LWOXGYIDLHBWQL-WCTZXXKLSA-N 0.000 description 1
• FFJZTSHFIURSSU-DBRKOABJSA-N 3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(hydroxyamino)-1-methyl-2h-1,3,5-triazin-4-one Chemical compound O=C1N=C(NO)N(C)CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 FFJZTSHFIURSSU-DBRKOABJSA-N 0.000 description 1
• AVRXOMHHZIEGHW-KVTDHHQDSA-N 3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-hydrazinyl-1-hydroxy-2h-1,3,5-triazin-4-one Chemical compound C1N(O)C(NN)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 AVRXOMHHZIEGHW-KVTDHHQDSA-N 0.000 description 1
• FEWJPZIEWOKRBE-UHFFFAOYSA-M 3-carboxy-2,3-dihydroxypropanoate Chemical compound OC(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-M 0.000 description 1
• NYZTVPYNKWYMIW-WRBBJXAJSA-N 4-[[2,3-bis[[(Z)-octadec-9-enoyl]oxy]propyl-dimethylazaniumyl]methyl]benzoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)CC1=CC=C(C=C1)C([O-])=O)OC(=O)CCCCCCC\C=C/CCCCCCCC NYZTVPYNKWYMIW-WRBBJXAJSA-N 0.000 description 1
• PFJBDCNEHIXTLU-VPCXQMTMSA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one Chemical group O=C1N=C(N)C=CN1[C@@]1(CO)[C@H](O)[C@H](O)[C@@H](CO)O1 PFJBDCNEHIXTLU-VPCXQMTMSA-N 0.000 description 1
• VOEJKTLBNFDGGT-JXOAFFINSA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(methylamino)pyrimidin-2-one Chemical compound O=C1N=C(N)C(NC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 VOEJKTLBNFDGGT-JXOAFFINSA-N 0.000 description 1
• UEHXEKJKNOHULW-FDDDBJFASA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-ethylpyrimidin-2-one Chemical compound O=C1N=C(N)C(CC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 UEHXEKJKNOHULW-FDDDBJFASA-N 0.000 description 1
• OZHIJZYBTCTDQC-JXOAFFINSA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2-thione Chemical compound S=C1N=C(N)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 OZHIJZYBTCTDQC-JXOAFFINSA-N 0.000 description 1
• NGCMLYZVLNLYTA-UAKXSSHOSA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-nitropyrimidin-2-one Chemical compound C1=C([N+]([O-])=O)C(N)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NGCMLYZVLNLYTA-UAKXSSHOSA-N 0.000 description 1
• PXACTUVBBMDKRW-UHFFFAOYSA-N 4-bromobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(Br)C=C1 PXACTUVBBMDKRW-UHFFFAOYSA-N 0.000 description 1
• OBKXEAXTFZPCHS-UHFFFAOYSA-N 4-phenylbutyric acid Chemical compound OC(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-N 0.000 description 1
• KQZVCLUNYWVFJY-JEMLMZEFSA-N 5-[(2S,3R,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-pyrimidine-2,4-dione Chemical compound O[C@@]1([C@H](O)[C@H](O)[C@@H](CO)O1)C1=CNC(=O)NC1=O KQZVCLUNYWVFJY-JEMLMZEFSA-N 0.000 description 1
• DXEJZRDJXRVUPN-UHFFFAOYSA-N 5-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-methyl-1h-pyrimidine-2,4-dione Chemical compound O=C1N(C)C(=O)NC=C1C1C(O)C(O)C(CO)O1 DXEJZRDJXRVUPN-UHFFFAOYSA-N 0.000 description 1
• PRZPQRIVPUNQTO-JXOAFFINSA-N 5-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(methylamino)pyrimidin-2-one Chemical compound C1=C(N)C(NC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 PRZPQRIVPUNQTO-JXOAFFINSA-N 0.000 description 1
• PXAVPJLBJSKTBJ-UAKXSSHOSA-N 5-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydrazinylpyrimidin-2-one Chemical compound C1=C(N)C(NN)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 PXAVPJLBJSKTBJ-UAKXSSHOSA-N 0.000 description 1
• GEHRSERUQRFUFW-UHFFFAOYSA-N 5-ethylhex-2-ynedioic acid Chemical compound CCC(C(O)=O)CC#CC(O)=O GEHRSERUQRFUFW-UHFFFAOYSA-N 0.000 description 1
• OZTOEARQSSIFOG-MWKIOEHESA-N 6-Thio-7-deaza-8-azaguanosine Chemical compound Nc1nc(=S)c2cnn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2[nH]1 OZTOEARQSSIFOG-MWKIOEHESA-N 0.000 description 1
• PRKXZPRMTSMQEP-KVTDHHQDSA-N 6-amino-3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1-hydroxy-2h-1,3,5-triazin-4-one Chemical compound C1N(O)C(N)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 PRKXZPRMTSMQEP-KVTDHHQDSA-N 0.000 description 1
• OHMBAVJOBLEQPZ-DBRKOABJSA-N 6-amino-3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1-methyl-2h-1,3,5-triazin-4-one Chemical compound O=C1N=C(N)N(C)CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 OHMBAVJOBLEQPZ-DBRKOABJSA-N 0.000 description 1
• OAUKGFJQZRGECT-UUOKFMHZSA-N 8-Azaadenosine Chemical compound N1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OAUKGFJQZRGECT-UUOKFMHZSA-N 0.000 description 1
• 208000030507 AIDS Diseases 0.000 description 1
• 244000215068 Acacia senegal Species 0.000 description 1
• 235000006491 Acacia senegal Nutrition 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
• ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 1
• ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
• 201000004384 Alopecia Diseases 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 208000024827 Alzheimer disease Diseases 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
• 101150023320 B16R gene Proteins 0.000 description 1
• 101150115284 BIRC5 gene Proteins 0.000 description 1
• 101100396232 Bombyx mori EN03 gene Proteins 0.000 description 1
• 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 1
• 108010049974 Bone Morphogenetic Protein 6 Proteins 0.000 description 1
• 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 1
• 102100022525 Bone morphogenetic protein 6 Human genes 0.000 description 1
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
• 101150013553 CD40 gene Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
• 102000020313 Cell-Penetrating Peptides Human genes 0.000 description 1
• 108010051109 Cell-Penetrating Peptides Proteins 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
• 108020004705 Codon Proteins 0.000 description 1
• 206010052360 Colorectal adenocarcinoma Diseases 0.000 description 1
• 206010053138 Congenital aplastic anaemia Diseases 0.000 description 1
• 206010056370 Congestive cardiomyopathy Diseases 0.000 description 1
• DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 description 1
• RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
• 230000008836 DNA modification Effects 0.000 description 1
• XULFJDKZVHTRLG-JDVCJPALSA-N DOSPA trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F.CCCCCCCC\C=C/CCCCCCCCOCC(C[N+](C)(C)CCNC(=O)C(CCCNCCCN)NCCCN)OCCCCCCCC\C=C/CCCCCCCC XULFJDKZVHTRLG-JDVCJPALSA-N 0.000 description 1
• 206010012289 Dementia Diseases 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
• 201000010046 Dilated cardiomyopathy Diseases 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 102100031780 Endonuclease Human genes 0.000 description 1
• 108010042407 Endonucleases Proteins 0.000 description 1
• 102400001368 Epidermal growth factor Human genes 0.000 description 1
• 101800003838 Epidermal growth factor Proteins 0.000 description 1
• 241000283074 Equus asinus Species 0.000 description 1
• 208000010228 Erectile Dysfunction Diseases 0.000 description 1
• 102100031939 Erythropoietin Human genes 0.000 description 1
• 108090000394 Erythropoietin Proteins 0.000 description 1
• 108091029865 Exogenous DNA Proteins 0.000 description 1
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
• 201000004939 Fanconi anemia Diseases 0.000 description 1
• BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
• XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 description 1
• 229920000084 Gum arabic Polymers 0.000 description 1
• 206010019233 Headaches Diseases 0.000 description 1
• 101001008907 Homo sapiens 2'-5'-oligoadenylate synthase 1 Proteins 0.000 description 1
• 101001008910 Homo sapiens 2'-5'-oligoadenylate synthase 2 Proteins 0.000 description 1
• 101000597332 Homo sapiens 2'-5'-oligoadenylate synthase 3 Proteins 0.000 description 1
• 101000597360 Homo sapiens 2'-5'-oligoadenylate synthase-like protein Proteins 0.000 description 1
• 101000823116 Homo sapiens Alpha-1-antitrypsin Proteins 0.000 description 1
• 101000914673 Homo sapiens Fanconi anemia group A protein Proteins 0.000 description 1
• 101001002470 Homo sapiens Interferon lambda-1 Proteins 0.000 description 1
• 101001082065 Homo sapiens Interferon-induced protein with tetratricopeptide repeats 1 Proteins 0.000 description 1
• 101001082058 Homo sapiens Interferon-induced protein with tetratricopeptide repeats 2 Proteins 0.000 description 1
• 101001082060 Homo sapiens Interferon-induced protein with tetratricopeptide repeats 3 Proteins 0.000 description 1
• 101001082063 Homo sapiens Interferon-induced protein with tetratricopeptide repeats 5 Proteins 0.000 description 1
• 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 1
• 101000853000 Homo sapiens Interleukin-26 Proteins 0.000 description 1
• 101000998139 Homo sapiens Interleukin-32 Proteins 0.000 description 1
• 101001055222 Homo sapiens Interleukin-8 Proteins 0.000 description 1
• 101001128431 Homo sapiens Myeloid-derived growth factor Proteins 0.000 description 1
• 101000595918 Homo sapiens Phospholipase A and acyltransferase 4 Proteins 0.000 description 1
• 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
• 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 description 1
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
• 101000610604 Homo sapiens Tumor necrosis factor receptor superfamily member 10B Proteins 0.000 description 1
• 101000610609 Homo sapiens Tumor necrosis factor receptor superfamily member 10D Proteins 0.000 description 1
• 101000798130 Homo sapiens Tumor necrosis factor receptor superfamily member 11B Proteins 0.000 description 1
• 101000648505 Homo sapiens Tumor necrosis factor receptor superfamily member 12A Proteins 0.000 description 1
• 101000795167 Homo sapiens Tumor necrosis factor receptor superfamily member 13B Proteins 0.000 description 1
• 101000795169 Homo sapiens Tumor necrosis factor receptor superfamily member 13C Proteins 0.000 description 1
• 101000648507 Homo sapiens Tumor necrosis factor receptor superfamily member 14 Proteins 0.000 description 1
• 101000801255 Homo sapiens Tumor necrosis factor receptor superfamily member 17 Proteins 0.000 description 1
• 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 description 1
• 101000801227 Homo sapiens Tumor necrosis factor receptor superfamily member 19 Proteins 0.000 description 1
• 101000801228 Homo sapiens Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 description 1
• 101000801232 Homo sapiens Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 description 1
• 101000679921 Homo sapiens Tumor necrosis factor receptor superfamily member 21 Proteins 0.000 description 1
• 101000679903 Homo sapiens Tumor necrosis factor receptor superfamily member 25 Proteins 0.000 description 1
• 101000679857 Homo sapiens Tumor necrosis factor receptor superfamily member 3 Proteins 0.000 description 1
• 101000679851 Homo sapiens Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 1
• 101000597785 Homo sapiens Tumor necrosis factor receptor superfamily member 6B Proteins 0.000 description 1
• 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 description 1
• 241000725303 Human immunodeficiency virus Species 0.000 description 1
• 208000023105 Huntington disease Diseases 0.000 description 1
• 102000003918 Hyaluronan Synthases Human genes 0.000 description 1
• 108090000320 Hyaluronan Synthases Proteins 0.000 description 1
• 206010020710 Hyperphagia Diseases 0.000 description 1
• 208000004044 Hypesthesia Diseases 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
• 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
• 102100026720 Interferon beta Human genes 0.000 description 1
• 102100020990 Interferon lambda-1 Human genes 0.000 description 1
• 108010047761 Interferon-alpha Proteins 0.000 description 1
• 102100027355 Interferon-induced protein with tetratricopeptide repeats 1 Human genes 0.000 description 1
• 102100027303 Interferon-induced protein with tetratricopeptide repeats 2 Human genes 0.000 description 1
• 102100027302 Interferon-induced protein with tetratricopeptide repeats 3 Human genes 0.000 description 1
• 102100027356 Interferon-induced protein with tetratricopeptide repeats 5 Human genes 0.000 description 1
• 102100034170 Interferon-induced, double-stranded RNA-activated protein kinase Human genes 0.000 description 1
• 101710089751 Interferon-induced, double-stranded RNA-activated protein kinase Proteins 0.000 description 1
• 102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 102000000589 Interleukin-1 Human genes 0.000 description 1
• 108010002352 Interleukin-1 Proteins 0.000 description 1
• 102000003815 Interleukin-11 Human genes 0.000 description 1
• 108090000177 Interleukin-11 Proteins 0.000 description 1
• 102000013462 Interleukin-12 Human genes 0.000 description 1
• 108010065805 Interleukin-12 Proteins 0.000 description 1
• 102100020789 Interleukin-15 receptor subunit alpha Human genes 0.000 description 1
• 101710107699 Interleukin-15 receptor subunit alpha Proteins 0.000 description 1
• 102000049772 Interleukin-16 Human genes 0.000 description 1
• 101800003050 Interleukin-16 Proteins 0.000 description 1
• 102000013691 Interleukin-17 Human genes 0.000 description 1
• 108050003558 Interleukin-17 Proteins 0.000 description 1
• 102100033096 Interleukin-17D Human genes 0.000 description 1
• 102000003810 Interleukin-18 Human genes 0.000 description 1
• 108090000171 Interleukin-18 Proteins 0.000 description 1
• 102100039879 Interleukin-19 Human genes 0.000 description 1
• 108050009288 Interleukin-19 Proteins 0.000 description 1
• 102000013264 Interleukin-23 Human genes 0.000 description 1
• 108010065637 Interleukin-23 Proteins 0.000 description 1
• 102100036679 Interleukin-26 Human genes 0.000 description 1
• 108010066979 Interleukin-27 Proteins 0.000 description 1
• 102100039064 Interleukin-3 Human genes 0.000 description 1
• 108010002386 Interleukin-3 Proteins 0.000 description 1
• 102100033501 Interleukin-32 Human genes 0.000 description 1
• 102000017761 Interleukin-33 Human genes 0.000 description 1
• 108010067003 Interleukin-33 Proteins 0.000 description 1
• 108091007973 Interleukin-36 Proteins 0.000 description 1
• 102000004388 Interleukin-4 Human genes 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 102000000743 Interleukin-5 Human genes 0.000 description 1
• 108010002616 Interleukin-5 Proteins 0.000 description 1
• 102000000704 Interleukin-7 Human genes 0.000 description 1
• 108010002586 Interleukin-7 Proteins 0.000 description 1
• 108090001007 Interleukin-8 Proteins 0.000 description 1
• 102000000585 Interleukin-9 Human genes 0.000 description 1
• 108010002335 Interleukin-9 Proteins 0.000 description 1
• 108010063738 Interleukins Proteins 0.000 description 1
• 206010048858 Ischaemic cardiomyopathy Diseases 0.000 description 1
• 108700021430 Kruppel-Like Factor 4 Proteins 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• 239000005639 Lauric acid Substances 0.000 description 1
• 241000713666 Lentivirus Species 0.000 description 1
• 108090000581 Leukemia inhibitory factor Proteins 0.000 description 1
• 102000004058 Leukemia inhibitory factor Human genes 0.000 description 1
• 102000003960 Ligases Human genes 0.000 description 1
• 108090000364 Ligases Proteins 0.000 description 1
• 239000012097 Lipofectamine 2000 Substances 0.000 description 1
• 239000012098 Lipofectamine RNAiMAX Substances 0.000 description 1
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 102100033342 Lysosomal acid glucosylceramidase Human genes 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
• 102100034216 Melanocyte-stimulating hormone receptor Human genes 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• AFVFQIVMOAPDHO-UHFFFAOYSA-M Methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
• 239000004909 Moisturizer Substances 0.000 description 1
• 101000650589 Mus musculus Roundabout homolog 3 Proteins 0.000 description 1
• XCUAIINAJCDIPM-XVFCMESISA-N N(4)-hydroxycytidine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=NO)C=C1 XCUAIINAJCDIPM-XVFCMESISA-N 0.000 description 1
• GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
• QIAFMBKCNZACKA-UHFFFAOYSA-N N-benzoylglycine Chemical compound OC(=O)CNC(=O)C1=CC=CC=C1 QIAFMBKCNZACKA-UHFFFAOYSA-N 0.000 description 1
• UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
• MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
• 229910002651 NO3 Inorganic materials 0.000 description 1
• 108010032605 Nerve Growth Factor Receptors Proteins 0.000 description 1
• 206010060860 Neurological symptom Diseases 0.000 description 1
• PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
• NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
• 108091034117 Oligonucleotide Proteins 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 240000007594 Oryza sativa Species 0.000 description 1
• 235000007164 Oryza sativa Nutrition 0.000 description 1
• MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
• 208000002193 Pain Diseases 0.000 description 1
• 208000018737 Parkinson disease Diseases 0.000 description 1
• 235000019483 Peanut oil Nutrition 0.000 description 1
• 102100035200 Phospholipase A and acyltransferase 4 Human genes 0.000 description 1
• 239000004698 Polyethylene Substances 0.000 description 1
• 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 1
• 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 1
• 229920002556 Polyethylene Glycol 300 Polymers 0.000 description 1
• 229920002560 Polyethylene Glycol 3000 Polymers 0.000 description 1
• 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
• 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
• 229920002582 Polyethylene Glycol 600 Polymers 0.000 description 1
• 229920002593 Polyethylene Glycol 800 Polymers 0.000 description 1
• 239000004743 Polypropylene Substances 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
• 102000009092 Proto-Oncogene Proteins c-myc Human genes 0.000 description 1
• 108010087705 Proto-Oncogene Proteins c-myc Proteins 0.000 description 1
• 239000012980 RPMI-1640 medium Substances 0.000 description 1
• 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 description 1
• 108010038036 Receptor Activator of Nuclear Factor-kappa B Proteins 0.000 description 1
• 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
• 241001068263 Replication competent viruses Species 0.000 description 1
• 108010044012 STAT1 Transcription Factor Proteins 0.000 description 1
• 102000004265 STAT2 Transcription Factor Human genes 0.000 description 1
• 108010081691 STAT2 Transcription Factor Proteins 0.000 description 1
• 206010040037 Sensory neuropathy hereditary Diseases 0.000 description 1
• 102100029904 Signal transducer and activator of transcription 1-alpha/beta Human genes 0.000 description 1
• 108020004459 Small interfering RNA Proteins 0.000 description 1
• 108091081024 Start codon Proteins 0.000 description 1
• 208000006011 Stroke Diseases 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• 108700012920 TNF Proteins 0.000 description 1
• 101150033527 TNF gene Proteins 0.000 description 1
• 108091007178 TNFRSF10A Proteins 0.000 description 1
• 229920002253 Tannate Polymers 0.000 description 1
• 102100032938 Telomerase reverse transcriptase Human genes 0.000 description 1
• 108091046869 Telomeric non-coding RNA Proteins 0.000 description 1
• 208000002903 Thalassemia Diseases 0.000 description 1
• 108090000190 Thrombin Proteins 0.000 description 1
• 208000009205 Tinnitus Diseases 0.000 description 1
• 102000002689 Toll-like receptor Human genes 0.000 description 1
• 108020000411 Toll-like receptor Proteins 0.000 description 1
• 102100024324 Toll-like receptor 3 Human genes 0.000 description 1
• 108020004566 Transfer RNA Proteins 0.000 description 1
• 102000004338 Transferrin Human genes 0.000 description 1
• 108090000901 Transferrin Proteins 0.000 description 1
• 206010044565 Tremor Diseases 0.000 description 1
• 102100040247 Tumor necrosis factor Human genes 0.000 description 1
• 102100040113 Tumor necrosis factor receptor superfamily member 10A Human genes 0.000 description 1
• 102100040112 Tumor necrosis factor receptor superfamily member 10B Human genes 0.000 description 1
• 102100040110 Tumor necrosis factor receptor superfamily member 10D Human genes 0.000 description 1
• 102100028787 Tumor necrosis factor receptor superfamily member 11A Human genes 0.000 description 1
• 102100032236 Tumor necrosis factor receptor superfamily member 11B Human genes 0.000 description 1
• 102100028786 Tumor necrosis factor receptor superfamily member 12A Human genes 0.000 description 1
• 102100029675 Tumor necrosis factor receptor superfamily member 13B Human genes 0.000 description 1
• 102100029690 Tumor necrosis factor receptor superfamily member 13C Human genes 0.000 description 1
• 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 description 1
• 102100033725 Tumor necrosis factor receptor superfamily member 16 Human genes 0.000 description 1
• 102100033726 Tumor necrosis factor receptor superfamily member 17 Human genes 0.000 description 1
• 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 description 1
• 102100033760 Tumor necrosis factor receptor superfamily member 19 Human genes 0.000 description 1
• 102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 description 1
• 102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 description 1
• 102100022205 Tumor necrosis factor receptor superfamily member 21 Human genes 0.000 description 1
• 102100022203 Tumor necrosis factor receptor superfamily member 25 Human genes 0.000 description 1
• 102100022202 Tumor necrosis factor receptor superfamily member 27 Human genes 0.000 description 1
• 102100022156 Tumor necrosis factor receptor superfamily member 3 Human genes 0.000 description 1
• 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 description 1
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 1
• 102100035284 Tumor necrosis factor receptor superfamily member 6B Human genes 0.000 description 1
• 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 description 1
• 108010021428 Type 1 Melanocortin Receptor Proteins 0.000 description 1
• 102000003425 Tyrosinase Human genes 0.000 description 1
• 108060008724 Tyrosinase Proteins 0.000 description 1
• PGAVKCOVUIYSFO-XVFCMESISA-N UTP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-XVFCMESISA-N 0.000 description 1
• 229910052770 Uranium Inorganic materials 0.000 description 1
• 101100316831 Vaccinia virus (strain Copenhagen) B18R gene Proteins 0.000 description 1
• 101100004099 Vaccinia virus (strain Western Reserve) VACWR200 gene Proteins 0.000 description 1
• 229930003316 Vitamin D Natural products 0.000 description 1
• QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
• 206010052428 Wound Diseases 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• 108010054754 Xedar Receptor Proteins 0.000 description 1
• 201000006083 Xeroderma Pigmentosum Diseases 0.000 description 1
• ZZXDRXVIRVJQBT-UHFFFAOYSA-M Xylenesulfonate Chemical compound CC1=CC=CC(S([O-])(=O)=O)=C1C ZZXDRXVIRVJQBT-UHFFFAOYSA-M 0.000 description 1
• SIIZPVYVXNXXQG-KGXOGWRBSA-N [(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-4-[[(3s,4r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-hydroxyoxolan-2-yl]methyl [(2r,4r,5r)-2-(6-aminopurin-9-yl)-4-hydroxy-5-(phosphonooxymethyl)oxolan-3-yl] hydrogen phosphate Polymers C1=NC2=C(N)N=CN=C2N1[C@@H]1O[C@H](COP(O)(=O)OC2[C@@H](O[C@H](COP(O)(O)=O)[C@H]2O)N2C3=NC=NC(N)=C3N=C2)[C@@H](O)[C@H]1OP(O)(=O)OCC([C@@H](O)[C@H]1O)OC1N1C(N=CN=C2N)=C2N=C1 SIIZPVYVXNXXQG-KGXOGWRBSA-N 0.000 description 1
• ALRIWCIIGVAXHV-UHFFFAOYSA-N [3-(dimethylamino)-2-hexadecanoyloxypropyl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CN(C)C)OC(=O)CCCCCCCCCCCCCCC ALRIWCIIGVAXHV-UHFFFAOYSA-N 0.000 description 1
• RVBUSVJSKGVQQS-UHFFFAOYSA-N [3-(dimethylamino)-2-octadecanoyloxypropyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CN(C)C)OC(=O)CCCCCCCCCCCCCCCCC RVBUSVJSKGVQQS-UHFFFAOYSA-N 0.000 description 1
• QUQHEMSUWCJRBP-UHFFFAOYSA-N [3-(dimethylamino)-2-tetradecanoyloxypropyl] tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CN(C)C)OC(=O)CCCCCCCCCCCCC QUQHEMSUWCJRBP-UHFFFAOYSA-N 0.000 description 1
• 210000001015 abdomen Anatomy 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 235000010489 acacia gum Nutrition 0.000 description 1
• IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
• 239000008186 active pharmaceutical agent Substances 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• 229960001456 adenosine triphosphate Drugs 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 229910052783 alkali metal Inorganic materials 0.000 description 1
• 150000001340 alkali metals Chemical class 0.000 description 1
• 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
• 150000001342 alkaline earth metals Chemical class 0.000 description 1
• 150000003973 alkyl amines Chemical class 0.000 description 1
• 125000000217 alkyl group Chemical group 0.000 description 1
• 101150087698 alpha gene Proteins 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 229910021529 ammonia Inorganic materials 0.000 description 1
• SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 description 1
• BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
• 235000011130 ammonium sulphate Nutrition 0.000 description 1
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
• 239000003098 androgen Substances 0.000 description 1
• 206010068168 androgenetic alopecia Diseases 0.000 description 1
• 201000002996 androgenic alopecia Diseases 0.000 description 1
• 208000022531 anorexia Diseases 0.000 description 1
• 230000001093 anti-cancer Effects 0.000 description 1
• 230000000840 anti-viral effect Effects 0.000 description 1
• 238000011394 anticancer treatment Methods 0.000 description 1
• 230000036528 appetite Effects 0.000 description 1
• 235000019789 appetite Nutrition 0.000 description 1
• 239000012736 aqueous medium Substances 0.000 description 1
• 239000007900 aqueous suspension Substances 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 229940072107 ascorbate Drugs 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• 239000012752 auxiliary agent Substances 0.000 description 1
• 229940077388 benzenesulfonate Drugs 0.000 description 1
• SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
• 239000003613 bile acid Substances 0.000 description 1
• 229940093761 bile salts Drugs 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 229920001400 block copolymer Polymers 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 229940077737 brain-derived neurotrophic factor Drugs 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• 210000001217 buttock Anatomy 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 244000309466 calf Species 0.000 description 1
• MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 239000004202 carbamide Substances 0.000 description 1
• 150000001721 carbon Chemical group 0.000 description 1
• 230000000747 cardiac effect Effects 0.000 description 1
• WYUSVOMTXWRGEK-HBWVYFAYSA-N cefpodoxime Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC)C(O)=O)C(=O)C(=N/OC)\C1=CSC(N)=N1 WYUSVOMTXWRGEK-HBWVYFAYSA-N 0.000 description 1
• 230000010094 cellular senescence Effects 0.000 description 1
• 239000003610 charcoal Substances 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• JOYKCMAPFCSKNO-UHFFFAOYSA-N chloro benzenesulfonate Chemical compound ClOS(=O)(=O)C1=CC=CC=C1 JOYKCMAPFCSKNO-UHFFFAOYSA-N 0.000 description 1
• KVSASDOGYIBWTA-UHFFFAOYSA-N chloro benzoate Chemical compound ClOC(=O)C1=CC=CC=C1 KVSASDOGYIBWTA-UHFFFAOYSA-N 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 229940114081 cinnamate Drugs 0.000 description 1
• 239000008119 colloidal silica Substances 0.000 description 1
• 238000010668 complexation reaction Methods 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 229940104302 cytosine Drugs 0.000 description 1
• GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
• 206010061428 decreased appetite Diseases 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 238000012217 deletion Methods 0.000 description 1
• 230000037430 deletion Effects 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 230000018109 developmental process Effects 0.000 description 1
• 229920000359 diblock copolymer Polymers 0.000 description 1
• UMGXUWVIJIQANV-UHFFFAOYSA-M didecyl(dimethyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC UMGXUWVIJIQANV-UHFFFAOYSA-M 0.000 description 1
• ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
• HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 238000006471 dimerization reaction Methods 0.000 description 1
• OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 1
• 239000002270 dispersing agent Substances 0.000 description 1
• 239000006185 dispersion Substances 0.000 description 1
• 208000002173 dizziness Diseases 0.000 description 1
• 230000008482 dysregulation Effects 0.000 description 1
• 230000005684 electric field Effects 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 229940116977 epidermal growth factor Drugs 0.000 description 1
• 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
• 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
• 229940105423 erythropoietin Drugs 0.000 description 1
• 229940011871 estrogen Drugs 0.000 description 1
• 239000000262 estrogen Substances 0.000 description 1
• RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
• LIWAQLJGPBVORC-UHFFFAOYSA-N ethylmethylamine Chemical compound CCNC LIWAQLJGPBVORC-UHFFFAOYSA-N 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 238000013401 experimental design Methods 0.000 description 1
• 210000004709 eyebrow Anatomy 0.000 description 1
• 210000000720 eyelash Anatomy 0.000 description 1
• 206010016256 fatigue Diseases 0.000 description 1
• 230000035558 fertility Effects 0.000 description 1
• 231100000502 fertility decrease Toxicity 0.000 description 1
• 235000013312 flour Nutrition 0.000 description 1
• 210000001061 forehead Anatomy 0.000 description 1
• 239000003205 fragrance Substances 0.000 description 1
• 230000008014 freezing Effects 0.000 description 1
• 238000007710 freezing Methods 0.000 description 1
• 230000006870 function Effects 0.000 description 1
• 239000000499 gel Substances 0.000 description 1
• 229940050410 gluconate Drugs 0.000 description 1
• 229930195712 glutamate Natural products 0.000 description 1
• YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
• SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
• 210000003780 hair follicle Anatomy 0.000 description 1
• 230000003779 hair growth Effects 0.000 description 1
• 231100000869 headache Toxicity 0.000 description 1
• MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
• 208000037584 hereditary sensory and autonomic neuropathy Diseases 0.000 description 1
• 201000006847 hereditary sensory neuropathy Diseases 0.000 description 1
• 239000000833 heterodimer Substances 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
• 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
• 208000034783 hypoesthesia Diseases 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 229960003444 immunosuppressant agent Drugs 0.000 description 1
• 201000001881 impotence Diseases 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 230000015788 innate immune response Effects 0.000 description 1
• 102000006495 integrins Human genes 0.000 description 1
• 108010044426 integrins Proteins 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 229940047124 interferons Drugs 0.000 description 1
• 102000004114 interleukin 20 Human genes 0.000 description 1
• 108090000681 interleukin 20 Proteins 0.000 description 1
• 230000031261 interleukin-10 production Effects 0.000 description 1
• 108010074108 interleukin-21 Proteins 0.000 description 1
• 102000003898 interleukin-24 Human genes 0.000 description 1
• 108090000237 interleukin-24 Proteins 0.000 description 1
• 229940096397 interleukin-8 Drugs 0.000 description 1
• XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 1
• 229940118526 interleukin-9 Drugs 0.000 description 1
• 239000003456 ion exchange resin Substances 0.000 description 1
• 229920003303 ion-exchange polymer Polymers 0.000 description 1
• 230000000302 ischemic effect Effects 0.000 description 1
• KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
• TWBYWOBDOCUKOW-UHFFFAOYSA-M isonicotinate Chemical compound [O-]C(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-M 0.000 description 1
• 210000001847 jaw Anatomy 0.000 description 1
• 210000002510 keratinocyte Anatomy 0.000 description 1
• 230000003907 kidney function Effects 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 230000002045 lasting effect Effects 0.000 description 1
• 231100001231 less toxic Toxicity 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 108020001756 ligand binding domains Proteins 0.000 description 1
• 101150111214 lin-28 gene Proteins 0.000 description 1
• 229910052744 lithium Inorganic materials 0.000 description 1
• 239000006210 lotion Substances 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 230000001050 lubricating effect Effects 0.000 description 1
• 208000002780 macular degeneration Diseases 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• 229940049920 malate Drugs 0.000 description 1
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
• BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
• IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 1
• 231100000682 maximum tolerated dose Toxicity 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• IZYBEMGNIUSSAX-UHFFFAOYSA-N methyl benzenecarboperoxoate Chemical compound COOC(=O)C1=CC=CC=C1 IZYBEMGNIUSSAX-UHFFFAOYSA-N 0.000 description 1
• 229940095102 methyl benzoate Drugs 0.000 description 1
• 108091070501 miRNA Proteins 0.000 description 1
• 239000002480 mineral oil Substances 0.000 description 1
• 235000010446 mineral oil Nutrition 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 230000001333 moisturizer Effects 0.000 description 1
• 229920006030 multiblock copolymer Polymers 0.000 description 1
• 201000006938 muscular dystrophy Diseases 0.000 description 1
• 238000002703 mutagenesis Methods 0.000 description 1
• 231100000350 mutagenesis Toxicity 0.000 description 1
• YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
• PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
• KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
• 210000003739 neck Anatomy 0.000 description 1
• 238000006386 neutralization reaction Methods 0.000 description 1
• 230000003472 neutralizing effect Effects 0.000 description 1
• 235000001968 nicotinic acid Nutrition 0.000 description 1
• 239000011664 nicotinic acid Substances 0.000 description 1
• 125000004433 nitrogen atom Chemical group N* 0.000 description 1
• 231100000862 numbness Toxicity 0.000 description 1
• WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
• 230000009437 off-target effect Effects 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 235000019198 oils Nutrition 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 229940049964 oleate Drugs 0.000 description 1
• ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
• 239000006179 pH buffering agent Substances 0.000 description 1
• 230000036407 pain Effects 0.000 description 1
• 229940014662 pantothenate Drugs 0.000 description 1
• 235000019161 pantothenic acid Nutrition 0.000 description 1
• 239000011713 pantothenic acid Substances 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 239000000312 peanut oil Substances 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 229940090048 pen injector Drugs 0.000 description 1
• 239000003961 penetration enhancing agent Substances 0.000 description 1
• JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
• 239000000813 peptide hormone Substances 0.000 description 1
• 230000008447 perception Effects 0.000 description 1
• 230000010412 perfusion Effects 0.000 description 1
• 239000003208 petroleum Substances 0.000 description 1
• DYUMLJSJISTVPV-UHFFFAOYSA-N phenyl propanoate Chemical compound CCC(=O)OC1=CC=CC=C1 DYUMLJSJISTVPV-UHFFFAOYSA-N 0.000 description 1
• 229940049953 phenylacetate Drugs 0.000 description 1
• WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
• 229950009215 phenylbutanoic acid Drugs 0.000 description 1
• XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
• 230000019612 pigmentation Effects 0.000 description 1
• 229920002523 polyethylene Glycol 1000 Polymers 0.000 description 1
• 239000004626 polylactic acid Substances 0.000 description 1
• 208000022530 polyphagia Diseases 0.000 description 1
• 229920001155 polypropylene Polymers 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 229940002612 prodrug Drugs 0.000 description 1
• 239000000651 prodrug Substances 0.000 description 1
• 239000000186 progesterone Substances 0.000 description 1
• 229960003387 progesterone Drugs 0.000 description 1
• 210000001236 prokaryotic cell Anatomy 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• WGYKZJWCGVVSQN-UHFFFAOYSA-O propan-1-aminium Chemical compound CCC[NH3+] WGYKZJWCGVVSQN-UHFFFAOYSA-O 0.000 description 1
• 238000011321 prophylaxis Methods 0.000 description 1
• QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
• 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
• UORVCLMRJXCDCP-UHFFFAOYSA-M propynoate Chemical compound [O-]C(=O)C#C UORVCLMRJXCDCP-UHFFFAOYSA-M 0.000 description 1
• 229940121649 protein inhibitor Drugs 0.000 description 1
• 239000012268 protein inhibitor Substances 0.000 description 1
• 230000009325 pulmonary function Effects 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
• XKMLYUALXHKNFT-UHFFFAOYSA-N rGTP Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O XKMLYUALXHKNFT-UHFFFAOYSA-N 0.000 description 1
• 238000003753 real-time PCR Methods 0.000 description 1
• 102000005962 receptors Human genes 0.000 description 1
• 108020003175 receptors Proteins 0.000 description 1
• 230000007115 recruitment Effects 0.000 description 1
• 230000003252 repetitive effect Effects 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 210000001995 reticulocyte Anatomy 0.000 description 1
• 230000033764 rhythmic process Effects 0.000 description 1
• 108020004418 ribosomal RNA Proteins 0.000 description 1
• 235000009566 rice Nutrition 0.000 description 1
• 102220082166 rs201392711 Human genes 0.000 description 1
• 229960001860 salicylate Drugs 0.000 description 1
• 210000004761 scalp Anatomy 0.000 description 1
• 229940116351 sebacate Drugs 0.000 description 1
• CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 208000002491 severe combined immunodeficiency Diseases 0.000 description 1
• 208000007056 sickle cell anemia Diseases 0.000 description 1
• 230000011664 signaling Effects 0.000 description 1
• 239000000741 silica gel Substances 0.000 description 1
• 229910002027 silica gel Inorganic materials 0.000 description 1
• 235000020183 skimmed milk Nutrition 0.000 description 1
• 230000037067 skin hydration Effects 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
• 159000000000 sodium salts Chemical class 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 239000008247 solid mixture Substances 0.000 description 1
• 239000003549 soybean oil Substances 0.000 description 1
• 235000012424 soybean oil Nutrition 0.000 description 1
• 238000013222 sprague-dawley male rat Methods 0.000 description 1
• 238000012453 sprague-dawley rat model Methods 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• TYFQFVWCELRYAO-UHFFFAOYSA-L suberate(2-) Chemical compound [O-]C(=O)CCCCCCC([O-])=O TYFQFVWCELRYAO-UHFFFAOYSA-L 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
• 125000004434 sulfur atom Chemical group 0.000 description 1
• 230000000475 sunscreen effect Effects 0.000 description 1
• 239000000516 sunscreening agent Substances 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 239000000725 suspension Substances 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 229940095064 tartrate Drugs 0.000 description 1
• 230000004489 tear production Effects 0.000 description 1
• 108091035539 telomere Proteins 0.000 description 1
• 102000055501 telomere Human genes 0.000 description 1
• 210000003411 telomere Anatomy 0.000 description 1
• 238000012360 testing method Methods 0.000 description 1
• 230000008719 thickening Effects 0.000 description 1
• 239000002562 thickening agent Substances 0.000 description 1
• 229960004072 thrombin Drugs 0.000 description 1
• 229940113082 thymine Drugs 0.000 description 1
• 231100000886 tinnitus Toxicity 0.000 description 1
• 210000003371 toe Anatomy 0.000 description 1
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
• WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
• 239000012581 transferrin Substances 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 125000005270 trialkylamine group Chemical group 0.000 description 1
• 229920000428 triblock copolymer Polymers 0.000 description 1
• IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• 241000701161 unidentified adenovirus Species 0.000 description 1
• 241001529453 unidentified herpesvirus Species 0.000 description 1
• 241001430294 unidentified retrovirus Species 0.000 description 1
• 210000000689 upper leg Anatomy 0.000 description 1
• 229940035893 uracil Drugs 0.000 description 1
• PGAVKCOVUIYSFO-UHFFFAOYSA-N uridine-triphosphate Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-UHFFFAOYSA-N 0.000 description 1
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
• RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 description 1
• 235000013311 vegetables Nutrition 0.000 description 1
• 230000004304 visual acuity Effects 0.000 description 1
• 235000019166 vitamin D Nutrition 0.000 description 1
• 239000011710 vitamin D Substances 0.000 description 1
• 150000003710 vitamin D derivatives Chemical class 0.000 description 1
• 229940046008 vitamin d Drugs 0.000 description 1
• 238000009736 wetting Methods 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 230000029663 wound healing Effects 0.000 description 1
• 229940071104 xylenesulfonate Drugs 0.000 description 1